{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 984, "items": [{"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T21:16:23Z", "timestamp": 1575148583461}, "reference-count": 118, "publisher": "Informa Healthcare", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Expert Opinion on Emerging Drugs"], "published-print": {"date-parts": [[2004, 5]]}, "DOI": "10.1517/14728214.9.1.9", "type": "journal-article", "created": {"date-parts": [[2005, 5, 4]], "date-time": "2005-05-04T22:41:27Z", "timestamp": 1115246487000}, "page": "9-21", "source": "Crossref", "is-referenced-by-count": 47, "title": ["Potential therapeutic targets for neurokinin-1 receptor antagonists"], "prefix": "10.1517", "volume": "9", "author": [{"given": "Ruth A", "family": "Duffy", "sequence": "first", "affiliation": []}], "member": "3197", "published-online": {"date-parts": [[2005, 3, 2]]}, "reference": [{"key": "p_4_1154", "DOI": "10.1146/annurev.pharmtox.41.1.877", "doi-asserted-by": "publisher"}, {"key": "p_6_1155", "DOI": "10.1038/80826", "doi-asserted-by": "publisher"}, {"key": "p_7_1156", "author": "KIYAMA H", "first-page": "182", "year": "1998", "journal-title": "Japan."}, {"key": "p_8_1157", "DOI": "10.1038/ni1201-1088", "doi-asserted-by": "publisher"}, {"key": "p_9_1158", "DOI": "10.1073/pnas.0931458100", "doi-asserted-by": "publisher"}, {"key": "p_10_1159", "DOI": "10.1016/S0014-2999(99)00259-9", "doi-asserted-by": "publisher"}, {"key": "p_11_1160", "author": "GARLAND AM", "volume": "303", "first-page": "177", "year": "1994", "journal-title": "Biochem. J.", "DOI": "10.1042/bj3030177", "doi-asserted-by": "crossref"}, {"key": "p_12_1161", "author": "MUSSAP CJ", "volume": "60", "first-page": "1987", "year": "1993", "journal-title": "J. Neurochem.", "DOI": "10.1111/j.1471-4159.1993.tb03484.x", "doi-asserted-by": "crossref"}, {"key": "p_13_1162", "author": "BELLUCCI F", "volume": "135", "first-page": "266", "year": "2002", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1038/sj.bjp.0704443", "doi-asserted-by": "crossref"}, {"key": "p_14_1163", "DOI": "10.1016/S0028-3908(03)00150-3", "doi-asserted-by": "publisher"}, {"key": "p_15_1164", "DOI": "10.1016/0006-8993(84)90470-0", "doi-asserted-by": "publisher"}, {"key": "p_16_1165", "author": "MANTYH PW", "volume": "63", "first-page": "6", "year": "2002", "journal-title": "J. Clin. Psychiatry"}, {"key": "p_17_1166", "author": "OTSUKA M", "volume": "73", "first-page": "229", "year": "1993", "journal-title": "Physiol. Rev.", "DOI": "10.1152/physrev.1993.73.2.229", "doi-asserted-by": "crossref"}, {"key": "p_18_1167", "unstructured": "WORLD HEALTHORGANIZATION: Disease burden measured in diabilityadjusted life years. (1990)."}, {"key": "p_19_1168", "DOI": "10.1038/nn943", "doi-asserted-by": "publisher"}, {"key": "p_20_1169", "DOI": "10.2165/00003495-200060030-00002", "doi-asserted-by": "publisher"}, {"key": "p_21_1170", "author": "BOLSER DC", "volume": "121", "first-page": "165", "year": "1997", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1038/sj.bjp.0701111", "doi-asserted-by": "crossref"}, {"key": "p_22_1171", "DOI": "10.1002/jemt.1081", "doi-asserted-by": "publisher"}, {"key": "p_23_1172", "DOI": "10.1016/S0165-6147(99)01396-6", "doi-asserted-by": "publisher"}, {"key": "p_24_1173", "DOI": "10.1126/science.281.5383.1640", "doi-asserted-by": "publisher"}, {"key": "p_25_1174", "author": "KRISHNAN KR", "volume": "63", "first-page": "25", "year": "2002", "journal-title": "J. Clin. Psychiatry"}, {"key": "p_26_1175", "DOI": "10.1038/sj.npp.1300260", "doi-asserted-by": "publisher"}, {"key": "p_28_1176", "DOI": "10.1002/(SICI)1098-1128(199607)16:4<297::AID-MED1>3.0.CO;2-S", "doi-asserted-by": "publisher"}, {"key": "p_29_1177", "author": "FONG TM", "volume": "267", "first-page": "25668", "year": "1992", "journal-title": "J. Biol. Chem."}, {"key": "p_30_1178", "DOI": "10.1016/S0165-6147(00)01502-9", "doi-asserted-by": "publisher"}, {"key": "p_31_1179", "DOI": "10.1016/S0165-6147(00)01578-9", "doi-asserted-by": "publisher"}, {"key": "p_32_1180", "DOI": "10.1016/S0009-9236(98)90140-0", "doi-asserted-by": "publisher"}, {"key": "p_33_1181", "DOI": "10.1016/S0889-857X(01)00006-0", "doi-asserted-by": "publisher"}, {"key": "p_34_1182", "DOI": "10.1016/S0889-857X(01)00004-7", "doi-asserted-by": "publisher"}, {"key": "p_35_1183", "author": "BESTER H", "volume": "21", "first-page": "1039", "year": "2001", "journal-title": "J. Neurosci.", "DOI": "10.1523/JNEUROSCI.21-03-01039.2001", "doi-asserted-by": "crossref"}, {"key": "p_36_1184", "DOI": "10.1016/S0306-4522(00)00148-2", "doi-asserted-by": "publisher"}, {"key": "p_37_1185", "DOI": "10.1016/0014-2999(93)90879-M", "doi-asserted-by": "publisher"}, {"key": "p_38_1186", "author": "LEE WS", "volume": "112", "first-page": "920", "year": "1994", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.1994.tb13168.x", "doi-asserted-by": "crossref"}, {"key": "p_39_1187", "DOI": "10.1016/0028-3908(94)00153-J", "doi-asserted-by": "publisher"}, {"key": "p_40_1188", "DOI": "10.1016/0014-2999(94)90198-8", "doi-asserted-by": "publisher"}, {"key": "p_41_1189", "DOI": "10.1016/S0006-8993(99)01976-9", "doi-asserted-by": "publisher"}, {"key": "p_42_1190", "DOI": "10.1016/S0893-133X(02)00313-5", "doi-asserted-by": "publisher"}, {"key": "p_43_1191", "DOI": "10.1016/S0028-3908(00)00052-6", "doi-asserted-by": "publisher"}, {"key": "p_44_1192", "DOI": "10.1124/jpet.301.2.536", "doi-asserted-by": "publisher"}, {"key": "p_45_1193", "DOI": "10.1016/S0028-3908(01)00051-X", "doi-asserted-by": "publisher"}, {"key": "p_46_1194", "DOI": "10.1016/S0306-4522(01)00467-5", "doi-asserted-by": "publisher"}, {"key": "p_47_1195", "author": "CONLEY RK", "volume": "22", "first-page": "7730", "year": "2002", "journal-title": "J. Neurosci.", "DOI": "10.1523/JNEUROSCI.22-17-07730.2002", "doi-asserted-by": "crossref"}, {"key": "p_48_1196", "DOI": "10.1016/S0006-3223(99)00177-8", "doi-asserted-by": "publisher"}, {"key": "p_49_1197", "DOI": "10.1038/sj.mp.4001130", "doi-asserted-by": "publisher"}, {"key": "p_50_1198", "DOI": "10.1016/S0028-3908(99)00172-0", "doi-asserted-by": "publisher"}, {"key": "p_51_1199", "DOI": "10.1016/0014-2999(96)00216-6", "doi-asserted-by": "publisher"}, {"key": "p_52_1200", "DOI": "10.1016/S0014-2999(97)85415-5", "doi-asserted-by": "publisher"}, {"key": "p_54_1201", "DOI": "10.1016/S0014-2999(98)00920-0", "doi-asserted-by": "publisher"}, {"key": "p_55_1202", "DOI": "10.1046/j.1474-8673.2003.00279.x", "doi-asserted-by": "publisher"}, {"key": "p_56_1203", "DOI": "10.1016/S0024-3205(02)02372-X", "doi-asserted-by": "publisher"}, {"key": "p_57_1204", "author": "AMADESI S", "volume": "163", "first-page": "1206", "year": "2001", "journal-title": "Am. J. Respir. Crit. Care", "DOI": "10.1164/ajrccm.163.5.2002079", "doi-asserted-by": "crossref"}, {"key": "p_58_1205", "author": "MUTOH T", "volume": "279", "first-page": "1215", "year": "2000", "journal-title": "Am. J. Physiol. Regul. Integr. Comp. Physiol.", "DOI": "10.1152/ajpregu.2000.279.4.R1215", "doi-asserted-by": "crossref"}, {"key": "p_59_1206", "DOI": "10.1113/jphysiol.2003.051326", "doi-asserted-by": "publisher"}, {"key": "p_60_1207", "DOI": "10.1046/j.1440-1843.2001.00333.x", "doi-asserted-by": "publisher"}, {"key": "p_61_1208", "DOI": "10.1183/09031936.02.00250902", "doi-asserted-by": "publisher"}, {"key": "p_62_1209", "DOI": "10.1016/S0014-2999(03)02189-7", "doi-asserted-by": "publisher"}, {"key": "p_63_1210", "DOI": "10.1038/sj.bjp.0705029", "doi-asserted-by": "publisher"}, {"key": "p_64_1211", "DOI": "10.1164/rccm.2110092", "doi-asserted-by": "publisher"}, {"key": "p_65_1212", "DOI": "10.1517/14728222.7.3.343", "doi-asserted-by": "publisher"}, {"key": "p_67_1213", "DOI": "10.1183/09031936.95.08071110", "doi-asserted-by": "publisher"}, {"key": "p_68_1214", "DOI": "10.1016/j.pupt.2003.08.002", "doi-asserted-by": "publisher"}, {"key": "p_69_1215", "author": "FAHY JV", "volume": "152", "first-page": "879", "year": "1995", "journal-title": "Am. J. Respir. Crit. Care Med.", "DOI": "10.1164/ajrccm.152.3.7663799", "doi-asserted-by": "crossref"}, {"key": "p_70_1216", "author": "OKANO S", "volume": "298", "first-page": "559", "year": "2001", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "p_71_1217", "DOI": "10.1124/jpet.300.3.925", "doi-asserted-by": "publisher"}, {"key": "p_72_1218", "DOI": "10.1016/S0014-2999(99)00313-1", "doi-asserted-by": "publisher"}, {"key": "p_73_1219", "DOI": "10.1016/S0091-3057(03)00032-7", "doi-asserted-by": "publisher"}, {"key": "p_74_1220", "DOI": "10.1016/S0196-9781(03)00161-X", "doi-asserted-by": "publisher"}, {"key": "p_75_1221", "DOI": "10.1016/S0306-4522(02)00660-7", "doi-asserted-by": "publisher"}, {"key": "p_76_1222", "author": "RENZI D", "volume": "157", "first-page": "1511", "year": "2000", "journal-title": "Am. J. Pathol.", "DOI": "10.1016/S0002-9440(10)64789-X", "doi-asserted-by": "crossref"}, {"key": "p_77_1223", "author": "SABAN R", "volume": "156", "first-page": "775", "year": "2000", "journal-title": "Am. J. Pathol.", "DOI": "10.1016/S0002-9440(10)64944-9", "doi-asserted-by": "crossref"}, {"key": "p_78_1224", "DOI": "10.1016/S0304-3959(01)00288-3", "doi-asserted-by": "publisher"}, {"key": "p_79_1225", "DOI": "10.1016/S0891-0618(00)00115-0", "doi-asserted-by": "publisher"}, {"key": "p_80_1226", "author": "CHIEN CT", "volume": "284", "first-page": "F840", "year": "2003", "journal-title": "Am. J. Physiol. Renal. Physiol.", "DOI": "10.1152/ajprenal.00187.2002", "doi-asserted-by": "crossref"}, {"key": "p_81_1227", "DOI": "10.1254/jjp.86.165", "doi-asserted-by": "publisher"}, {"key": "p_82_1228", "author": "FAGERLI J", "volume": "6", "first-page": "737", "year": "1999", "journal-title": "Can. J. Urol."}, {"key": "p_83_1229", "author": "CALLSEN-CENCIC P", "volume": "14", "first-page": "115", "year": "1999", "journal-title": "Restor. Neurol. Neurosci."}, {"key": "p_84_1230", "DOI": "10.1038/sj.bjp.0703343", "doi-asserted-by": "publisher"}, {"key": "p_85_1231", "author": "BHATIA M", "volume": "284", "first-page": "G830", "year": "2002", "journal-title": "Am. J. Physiol. Ganstrointest. Liver Physiol.", "DOI": "10.1152/ajpgi.00140.2002", "doi-asserted-by": "crossref"}, {"key": "p_86_1232", "DOI": "10.1097/00006676-200307000-00018", "doi-asserted-by": "publisher"}, {"key": "p_87_1233", "DOI": "10.1016/S0923-1811(03)00070-7", "doi-asserted-by": "publisher"}, {"key": "p_88_1234", "DOI": "10.1023/B:PHAM.0000012157.80716.73", "doi-asserted-by": "publisher"}, {"key": "p_89_1235", "author": "RAMESHWAR P", "volume": "86", "first-page": "482", "year": "1995", "journal-title": "Blood"}, {"key": "p_90_1236", "DOI": "10.1016/S0165-5728(01)00439-8", "doi-asserted-by": "publisher"}, {"key": "p_91_1237", "DOI": "10.1016/S0165-5728(02)00262-X", "doi-asserted-by": "publisher"}, {"key": "p_92_1238", "author": "HO WZ", "volume": "7", "first-page": "867", "year": "2002", "journal-title": "CNS Sprectr.", "DOI": "10.1017/S1092852900022483", "doi-asserted-by": "crossref"}, {"key": "p_93_1239", "DOI": "10.1097/00002030-200110190-00019", "doi-asserted-by": "publisher"}, {"key": "p_94_1240", "DOI": "10.1073/pnas.071052298", "doi-asserted-by": "publisher"}, {"key": "p_95_1241", "DOI": "10.1016/S0165-5728(02)00164-9", "doi-asserted-by": "publisher"}, {"key": "p_96_1242", "author": "HENNIG IM", "volume": "61", "first-page": "786", "year": "1995", "journal-title": "Int. J. Cancer.", "DOI": "10.1002/ijc.2910610608", "doi-asserted-by": "crossref"}, {"key": "p_97_1243", "DOI": "10.1053/gast.1996.v110.pm8964396", "doi-asserted-by": "publisher"}, {"key": "p_98_1244", "DOI": "10.1073/pnas.97.1.388", "doi-asserted-by": "publisher"}, {"key": "p_99_1245", "author": "NOWICKI M", "volume": "41", "first-page": "33", "year": "2003", "journal-title": "Folia Histochem. Cytobiol."}, {"key": "p_100_1246", "DOI": "10.1038/sj.leu.2402920", "doi-asserted-by": "publisher"}, {"key": "p_101_1247", "DOI": "10.1002/(SICI)1099-1387(199812)4:8<486::AID-PSC168>3.3.CO;2-E", "doi-asserted-by": "publisher"}, {"key": "p_102_1248", "DOI": "10.1054/bjoc.2000.1362", "doi-asserted-by": "publisher"}, {"key": "p_103_1249", "author": "FRIESS H", "volume": "83", "first-page": "731", "year": "2003", "journal-title": "Lab. Invest.", "DOI": "10.1097/01.LAB.0000067499.57309.F6", "doi-asserted-by": "crossref"}, {"key": "p_104_1250", "DOI": "10.1046/j.1460-9568.1999.00462.x", "doi-asserted-by": "publisher"}, {"key": "p_105_1251", "DOI": "10.1038/35012069", "doi-asserted-by": "publisher"}, {"key": "p_106_1252", "DOI": "10.1016/S0169-328X(00)00205-9", "doi-asserted-by": "publisher"}, {"key": "p_107_1253", "DOI": "10.1038/sj.bjp.0704681", "doi-asserted-by": "publisher"}, {"key": "p_108_1254", "DOI": "10.1046/j.1460-9568.2003.02887.x", "doi-asserted-by": "publisher"}, {"key": "p_109_1255", "DOI": "10.1016/S0959-8049(02)00674-3", "doi-asserted-by": "publisher"}, {"key": "p_110_1256", "DOI": "10.1002/cncr.10516", "doi-asserted-by": "publisher"}, {"key": "p_111_1257", "DOI": "10.1016/S0959-8049(00)00416-0", "doi-asserted-by": "publisher"}, {"key": "p_112_1258", "DOI": "10.1016/S0028-3908(03)00023-6", "doi-asserted-by": "publisher"}, {"key": "p_113_1259", "author": "KAMEL A", "volume": "748", "first-page": "179", "year": "2000", "journal-title": "J. Chromatogr.", "DOI": "10.1016/S0378-4347(00)00361-3", "doi-asserted-by": "crossref"}, {"key": "p_114_1260", "DOI": "10.1016/S0731-7085(03)00025-6", "doi-asserted-by": "publisher"}, {"key": "p_115_1261", "DOI": "10.1016/S0378-4347(00)00252-8", "doi-asserted-by": "publisher"}, {"key": "p_116_1262", "author": "OBACH RS", "volume": "29", "first-page": "1599", "year": "2001", "journal-title": "Drug Metab. Dispos."}, {"key": "p_117_1263", "author": "OBACH RS", "volume": "29", "first-page": "1057", "year": "2001", "journal-title": "Drug Metab. Dispos."}, {"key": "p_118_1264", "DOI": "10.1097/00000542-200010000-00009", "doi-asserted-by": "publisher"}, {"key": "p_119_1265", "author": "MCLEAN S", "volume": "277", "first-page": "900", "year": "1996", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "p_120_1266", "DOI": "10.1016/j.tips.2003.09.011", "doi-asserted-by": "publisher"}, {"key": "p_121_1267", "DOI": "10.1124/jpet.102.034348", "doi-asserted-by": "publisher"}, {"key": "p_122_1268", "DOI": "10.1016/S0091-3057(01)00571-8", "doi-asserted-by": "publisher"}, {"key": "p_123_1269", "DOI": "10.1016/S0731-7085(00)00557-4", "doi-asserted-by": "publisher"}, {"key": "p_124_1270", "DOI": "10.1124/jpet.102.040162", "doi-asserted-by": "publisher"}, {"key": "p_125_1271", "DOI": "10.1124/jpet.102.040279", "doi-asserted-by": "publisher"}], "container-title": ["Expert Opinion on Emerging Drugs"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1517/14728214.9.1.9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 17]], "date-time": "2019-02-17T22:46:01Z", "timestamp": 1550443561000}, "score": 49.017742, "issued": {"date-parts": [[2004, 5]]}, "references-count": 118, "journal-issue": {"published-online": {"date-parts": [[2005, 3, 2]]}, "published-print": {"date-parts": [[2004, 5]]}, "issue": "1"}, "alternative-id": ["10.1517/14728214.9.1.9"], "URL": "http://dx.doi.org/10.1517/14728214.9.1.9", "relation": {"cites": []}, "ISSN": ["1472-8214", "1744-7623"], "issn-type": [{"value": "1472-8214", "type": "print"}, {"value": "1744-7623", "type": "electronic"}], "subject": ["Pharmacology (medical)", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:47:02Z", "timestamp": 1574484422790}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2011, 11, 12]]}, "DOI": "10.1158/1535-7163.targ-11-a59", "type": "proceedings-article", "created": {"date-parts": [[2012, 6, 27]], "date-time": "2012-06-27T06:38:41Z", "timestamp": 1340779121000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract A59: Wnt, Notch, and Hedgehog pathways as potential therapeutic targets in OCT4A expressing cancer stem cells of malignant melanoma."], "prefix": "10.1158", "author": [{"given": "Yvonne", "family": "Welte", "sequence": "first", "affiliation": []}, {"given": "Hella", "family": "Kohlhof", "sequence": "additional", "affiliation": []}, {"given": "Johann", "family": "Leban", "sequence": "additional", "affiliation": []}, {"given": "Christian RA", "family": "Regenbrecht", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 10, 24]]}, "event": {"name": "Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA"}, "container-title": ["Cancer Stem Cells"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1535-7163.TARG-11-A59", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 9]], "date-time": "2019-05-09T19:42:00Z", "timestamp": 1557430920000}, "score": 24.2555, "issued": {"date-parts": [[2011, 11, 12]]}, "references-count": 0, "alternative-id": ["10.1158/1535-7163.TARG-11-A59"], "URL": "http://dx.doi.org/10.1158/1535-7163.targ-11-a59"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T19:14:15Z", "timestamp": 1574536455969}, "reference-count": 78, "publisher": "Informa Healthcare", "issue": "9", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Expert Opinion on Therapeutic Targets"], "published-print": {"date-parts": [[2014, 9]]}, "DOI": "10.1517/14728222.2014.938050", "type": "journal-article", "created": {"date-parts": [[2014, 8, 2]], "date-time": "2014-08-02T06:40:11Z", "timestamp": 1406961611000}, "page": "999-1009", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 9, "title": ["cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?"], "prefix": "10.1517", "volume": "18", "author": [{"given": "Patricia B", "family": "Gaule", "sequence": "first", "affiliation": []}, {"given": "John", "family": "Crown", "sequence": "additional", "affiliation": []}, {"given": "Norma", "family": "O\u2019Donovan", "sequence": "additional", "affiliation": []}, {"given": "Michael J", "family": "Duffy", "sequence": "additional", "affiliation": []}], "member": "3197", "published-online": {"date-parts": [[2014, 8]]}, "reference": [{"issue": "9805", "key": "CIT0001", "doi-asserted-by": "crossref", "first-page": "1812", "DOI": "10.1016/S0140-6736(11)61539-0", "volume": "378", "author": "Reis-Filho JS", "year": "2011", "journal-title": "Lancet"}, {"issue": "19", "key": "CIT0002", "doi-asserted-by": "crossref", "first-page": "10869", "DOI": "10.1073/pnas.191367098", "volume": "98", "author": "S\u00f8rlie T", "year": "2001", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "14", "key": "CIT0003", "doi-asserted-by": "crossref", "first-page": "8418", "DOI": "10.1073/pnas.0932692100", "volume": "100", "author": "S\u00f8rlie T", "year": "2003", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "2", "key": "CIT0004", "doi-asserted-by": "crossref", "first-page": "264", "DOI": "10.1038/modpathol.3800528", "volume": "19", "author": "Livasy CA", "year": "2005", "journal-title": "Mod Pathol"}, {"issue": "3", "key": "CIT0005", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1002/ijc.21004", "volume": "116", "author": "Abd El-Rehim DM", "year": "2005", "journal-title": "Int J Cancer"}, {"issue": "16", "key": "CIT0006", "doi-asserted-by": "crossref", "first-page": "5367", "DOI": "10.1158/1078-0432.CCR-04-0220", "volume": "10", "author": "Nielsen TO", "year": "2004", "journal-title": "Clin Cancer Res"}, {"issue": "11", "key": "CIT0007", "doi-asserted-by": "crossref", "first-page": "1525", "DOI": "10.1097/01.LAB.0000038508.86221.B3", "volume": "82", "author": "Korsching E", "year": "2002", "journal-title": "Lab Invest"}, {"issue": "4", "key": "CIT0008", "doi-asserted-by": "crossref", "first-page": "360", "DOI": "10.1111/j.1075-122X.2006.00276.x", "volume": "12", "author": "Siziopikou KP", "year": "2006", "journal-title": "Breast J"}, {"issue": "7471", "key": "CIT0009", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1038/nature12634", "volume": "502", "author": "Kandoth C", "year": "2013", "journal-title": "Nature"}, {"issue": "20", "key": "CIT0010", "doi-asserted-by": "crossref", "first-page": "1938", "DOI": "10.1056/NEJMra1001389", "volume": "363", "author": "Foulkes WD", "year": "2010", "journal-title": "N Engl J Med"}, {"issue": "7", "key": "CIT0011", "doi-asserted-by": "crossref", "first-page": "2750", "DOI": "10.1172/JCI45014", "volume": "121", "author": "Lehmann BD", "year": "2011", "journal-title": "J Clin Invest"}, {"issue": "1", "key": "CIT0012", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1634/theoncologist.2011-S1-71", "volume": "16", "author": "Carey LA", "year": "2011", "journal-title": "Oncologist"}, {"key": "CIT0013", "DOI": "10.1002/ijc.27632", "doi-asserted-by": "publisher"}, {"issue": "31", "key": "CIT0014", "doi-asserted-by": "crossref", "first-page": "12909", "DOI": "10.1073/pnas.0810403106", "volume": "106", "author": "Graveel CR", "year": "2009", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "26", "key": "CIT0015", "doi-asserted-by": "crossref", "first-page": "3287", "DOI": "10.1200/JCO.2011.40.3774", "volume": "30", "author": "Blumenschein GR", "year": "2012", "journal-title": "J Clin Oncol"}, {"key": "CIT0016", "author": "Graveel CR", "volume": "5", "issue": "7", "year": "2013", "journal-title": "Cold Spring Harb Perspect Biol", "DOI": "10.1101/cshperspect.a009209", "doi-asserted-by": "crossref"}, {"issue": "5981", "key": "CIT0017", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1038/311029a0", "volume": "311", "author": "Cooper CS", "year": "1984", "journal-title": "Nature"}, {"issue": "18", "key": "CIT0018", "doi-asserted-by": "crossref", "first-page": "6379", "DOI": "10.1073/pnas.84.18.6379", "volume": "84", "author": "Park M", "year": "1987", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "1", "key": "CIT0019", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1016/S1359-6101(01)00029-6", "volume": "13", "author": "Gautam M", "year": "2002", "journal-title": "Cytokine Growth Factor Rev"}, {"issue": "1", "key": "CIT0020", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1038/bjc.1988.150", "volume": "58", "author": "Tempest PR", "year": "1988", "journal-title": "Br J Cancer"}, {"issue": "2", "key": "CIT0021", "doi-asserted-by": "crossref", "first-page": "311", "DOI": "10.1016/0014-5793(87)80475-1", "volume": "224", "author": "Nakamura T", "year": "1987", "journal-title": "FEBS Lett"}, {"issue": "30", "key": "CIT0022", "doi-asserted-by": "crossref", "first-page": "13264", "DOI": "10.1073/pnas.1005183107", "volume": "107", "author": "Tolbert WD", "year": "2010", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "4", "key": "CIT0023", "doi-asserted-by": "crossref", "first-page": "1793", "DOI": "10.1128/MCB.11.4.1793", "volume": "11", "author": "Naldini L", "year": "1991", "journal-title": "Mol Cell Biol"}, {"issue": "7", "key": "CIT0024", "doi-asserted-by": "crossref", "first-page": "1260", "DOI": "10.1016/j.ejca.2010.02.028", "volume": "46", "author": "Cecchi F", "year": "2010", "journal-title": "Eur J Cancer"}, {"key": "CIT0025", "DOI": "10.1038/ng0597-68", "doi-asserted-by": "publisher"}, {"issue": "2", "key": "CIT0026", "first-page": "307", "volume": "59", "author": "Park WS", "year": "1999", "journal-title": "Cancer Res"}, {"issue": "43", "key": "CIT0027", "doi-asserted-by": "crossref", "first-page": "4947", "DOI": "10.1038/sj.onc.1203874", "volume": "19", "author": "Lee J", "year": "2002", "journal-title": "Oncogene"}, {"issue": "37", "key": "CIT0028", "doi-asserted-by": "crossref", "first-page": "5221", "DOI": "10.1038/sj.onc.1202899", "volume": "18", "author": "Michieli P", "year": "1999", "journal-title": "Oncogene"}, {"issue": "2", "key": "CIT0029", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1002/path.4268", "volume": "232", "author": "Koeppen H", "year": "2014", "journal-title": "J Pathol"}, {"issue": "2", "key": "CIT0030", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.2217/fon.09.164", "volume": "6", "author": "Toschi L", "year": "2010", "journal-title": "Future Oncol"}, {"issue": "5827", "key": "CIT0031", "doi-asserted-by": "crossref", "first-page": "1039", "DOI": "10.1126/science.1141478", "volume": "316", "author": "Engelman JA", "year": "2007", "journal-title": "Science"}, {"issue": "1", "key": "CIT0032", "first-page": "225", "volume": "148", "author": "Tuck AB", "year": "1996", "journal-title": "Am J Pathol"}, {"issue": "1", "key": "CIT0033", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1111/j.1365-2559.2007.02732.x", "volume": "51", "author": "Lindemann K", "year": "2007", "journal-title": "Histopathology"}, {"issue": "8", "key": "CIT0034", "doi-asserted-by": "crossref", "first-page": "2269", "DOI": "10.1158/1078-0432.CCR-11-2830", "volume": "18", "author": "Raghav KP", "year": "2012", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "CIT0035", "doi-asserted-by": "crossref", "first-page": "R402", "DOI": "10.1186/bcr2239", "volume": "11", "author": "Carracedo A", "year": "2009", "journal-title": "Breast Cancer Res"}, {"issue": "3", "key": "CIT0036", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1002/(SICI)1097-0215(19970620)74:3<301::AID-IJC12>3.0.CO;2-E", "volume": "74", "author": "Beviglia L", "year": "1997", "journal-title": "Int J Cancer"}, {"issue": "3", "key": "CIT0037", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1046/j.1440-1827.2001.01182.x", "volume": "51", "author": "Edakuni G", "year": "2001", "journal-title": "Pathol Int"}, {"issue": "6", "key": "CIT0038", "doi-asserted-by": "crossref", "first-page": "830", "DOI": "10.1016/j.humpath.2006.11.015", "volume": "38", "author": "Garcia S", "year": "2007", "journal-title": "Hum Pathol"}, {"issue": "1", "key": "CIT0039", "first-page": "48", "volume": "31", "author": "Garcia S", "year": "2007", "journal-title": "Int J Oncol"}, {"issue": "4", "key": "CIT0040", "first-page": "678", "volume": "113", "author": "Lengyel E", "year": "2005", "journal-title": "Int J Oncol"}, {"issue": "5", "key": "CIT0041", "first-page": "1101", "volume": "63", "author": "Kang JY", "year": "2003", "journal-title": "Cancer Res"}, {"issue": "2", "key": "CIT0042", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1002/cncr.28386", "volume": "120", "author": "Ho-Yen CM", "year": "2014", "journal-title": "Cancer"}, {"issue": "10", "key": "CIT0043", "doi-asserted-by": "crossref", "first-page": "2424", "DOI": "10.1002/ijc.28566", "volume": "134", "author": "Kim YJ", "year": "2014", "journal-title": "Int J Cancer"}, {"issue": "8", "key": "CIT0044", "doi-asserted-by": "crossref", "first-page": "3200", "DOI": "10.1073/pnas.87.8.3200", "volume": "87", "author": "Tashiro K", "year": "1990", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "5", "key": "CIT0045", "first-page": "1707", "volume": "149", "author": "Yao Y", "year": "1996", "journal-title": "Am J Pathol"}, {"issue": "7", "key": "CIT0046", "first-page": "1630", "volume": "54", "author": "Yamashita J", "year": "1994", "journal-title": "Cancer Res"}, {"issue": "31", "key": "CIT0047", "doi-asserted-by": "crossref", "first-page": "12903", "DOI": "10.1073/pnas.0810402106", "volume": "106", "author": "Ponzo MG", "year": "2009", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "14", "key": "CIT0048", "doi-asserted-by": "crossref", "first-page": "E1301", "DOI": "10.1073/pnas.1210353110", "volume": "110", "author": "Knight JF", "year": "2013", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "22", "key": "CIT0049", "doi-asserted-by": "crossref", "first-page": "9391", "DOI": "10.1158/0008-5472.CAN-10-0911", "volume": "70", "author": "Hochgr\u00e4fe F", "year": "2010", "journal-title": "Cancer Res"}, {"issue": "15", "key": "CIT0050", "doi-asserted-by": "crossref", "first-page": "2273", "DOI": "10.1038/sj.onc.1209254", "volume": "25", "author": "Charafe-Jauffret E", "year": "2005", "journal-title": "Oncogene"}, {"issue": "8", "key": "CIT0051", "doi-asserted-by": "crossref", "first-page": "1420", "DOI": "10.1074/mcp.M700487-MCP200", "volume": "7", "author": "Gon\u00e7alves A", "year": "2008", "journal-title": "Mol Cell Proteomics"}, {"issue": "4", "key": "CIT0052", "doi-asserted-by": "crossref", "first-page": "208", "DOI": "10.1186/bcr2617", "volume": "12", "author": "Gastaldi S", "year": "2010", "journal-title": "Breast Cancer Res"}, {"key": "CIT0053", "author": "Gaule P", "volume": "31", "first-page": "abstract 1066", "year": "2011", "journal-title": "J Clin Oncol"}, {"issue": "9", "key": "CIT0054", "doi-asserted-by": "crossref", "first-page": "3314", "DOI": "10.1158/0008-5472.CAN-08-0132", "volume": "68", "author": "Mueller KL", "year": "2008", "journal-title": "Cancer Res"}, {"issue": "1", "key": "CIT0055", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.1186/1750-2187-5-8", "volume": "5", "author": "Mueller K", "year": "2010", "journal-title": "J Mol Signal"}, {"issue": "4", "key": "CIT0056", "doi-asserted-by": "crossref", "first-page": "R104", "DOI": "10.1186/bcr3224", "volume": "14", "author": "Mueller KL", "year": "2012", "journal-title": "Breast Cancer Res"}, {"issue": "24", "key": "CIT0057", "first-page": "abstract PD08-0", "volume": "71", "author": "Gartner E", "year": "2011", "journal-title": "Cancer Res"}, {"issue": "11", "key": "CIT0058", "doi-asserted-by": "crossref", "first-page": "1421", "DOI": "10.1038/onc.2008.485", "volume": "28", "author": "Finkbeiner MR", "year": "2009", "journal-title": "Oncogene"}, {"issue": "5", "key": "CIT0059", "doi-asserted-by": "crossref", "first-page": "R61", "DOI": "10.1186/bcr1767", "volume": "9", "author": "Stratford A", "year": "2007", "journal-title": "Breast Cancer Res"}, {"issue": "8", "key": "CIT0060", "doi-asserted-by": "crossref", "first-page": "645", "DOI": "10.1093/jnci/djr093", "volume": "103", "author": "De Bacco F", "year": "2011", "journal-title": "J Natl Cancer Inst"}, {"issue": "1", "key": "CIT0061", "doi-asserted-by": "crossref", "first-page": "e30143", "DOI": "10.1371/journal.pone.0030143", "volume": "7", "author": "Sun B", "year": "2012", "journal-title": "PLoS One"}, {"issue": "1", "key": "CIT0062", "doi-asserted-by": "crossref", "first-page": "e29124", "DOI": "10.1371/journal.pone.0029124", "volume": "7", "author": "Huang S", "year": "2012", "journal-title": "PLoS One"}, {"issue": "1", "key": "CIT0063", "doi-asserted-by": "crossref", "first-page": "214", "DOI": "10.1158/1535-7163.MCT-11-0277", "volume": "11", "author": "Previdi S", "year": "2012", "journal-title": "Mol Cancer Ther"}, {"issue": "2", "key": "CIT0064", "first-page": "237", "volume": "111", "author": "Prat M", "year": "1998", "journal-title": "J Cell Sci"}, {"key": "CIT0065", "DOI": "10.1073/pnas.1302725110", "doi-asserted-by": "publisher"}, {"issue": "32", "key": "CIT0066", "doi-asserted-by": "crossref", "first-page": "4105", "DOI": "10.1200/JCO.2012.47.4189", "volume": "31", "author": "Spigel DR", "year": "2013", "journal-title": "J Clin Oncol"}, {"key": "CIT0068", "author": "Dieras V", "volume": "73", "first-page": "abstract P2-16-", "year": "2013", "journal-title": "Cancer Res", "DOI": "10.1158/0008-5472.SABCS13-P2-16-01", "doi-asserted-by": "crossref"}, {"key": "CIT0069", "author": "Goldman JW", "volume": "31", "first-page": "abstract 1066", "year": "2013", "journal-title": "J Clin Oncol"}, {"issue": "8", "key": "CIT0070", "doi-asserted-by": "crossref", "first-page": "abstract 1738", "DOI": "10.1158/1538-7445.AM2012-1738", "volume": "72", "author": "Yan SB", "year": "2012", "journal-title": "Cancer Res"}, {"issue": "3", "key": "CIT0071", "doi-asserted-by": "crossref", "first-page": "526", "DOI": "10.1016/j.ygyno.2013.12.018", "volume": "132", "author": "Martin LP", "year": "2014", "journal-title": "Gynecol Oncol"}, {"key": "CIT0072", "DOI": "10.1158/0008-5472.CAN-12-3256", "doi-asserted-by": "publisher"}, {"key": "CIT0073", "DOI": "10.1158/1535-7163.MCT-09-1173", "doi-asserted-by": "publisher"}, {"key": "CIT0074", "author": "Rayson D", "volume": "30", "first-page": "abstract 1036", "year": "2012", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2012.42.2824", "doi-asserted-by": "crossref"}, {"issue": "10", "key": "CIT0075", "doi-asserted-by": "crossref", "first-page": "1447", "DOI": "10.1373/clinchem.2012.200477", "volume": "59", "author": "Duffy MJ", "year": "2013", "journal-title": "Clin Chem"}, {"key": "CIT0076", "DOI": "10.1200/JCO.2005.08.037", "doi-asserted-by": "publisher"}, {"issue": "5", "key": "CIT0077", "doi-asserted-by": "crossref", "first-page": "416", "DOI": "10.1016/j.ctrv.2011.10.003", "volume": "38", "author": "Soria J", "year": "2012", "journal-title": "Cancer Treat Rev"}, {"key": "CIT0078", "author": "Koeppen H", "year": "2014", "journal-title": "Clin Cancer Res"}, {"issue": "13", "key": "CIT0079", "doi-asserted-by": "crossref", "first-page": "4477", "DOI": "10.1073/pnas.0306068101", "volume": "101", "author": "Huh C", "year": "2004", "journal-title": "Proc Natl Acad Sci USA"}], "container-title": ["Expert Opinion on Therapeutic Targets"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1517/14728222.2014.938050", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 22]], "date-time": "2017-06-22T17:47:18Z", "timestamp": 1498153638000}, "score": 23.18612, "issued": {"date-parts": [[2014, 8]]}, "references-count": 78, "journal-issue": {"published-online": {"date-parts": [[2014, 6, 24]]}, "published-print": {"date-parts": [[2014, 9]]}, "issue": "9"}, "alternative-id": ["10.1517/14728222.2014.938050"], "URL": "http://dx.doi.org/10.1517/14728222.2014.938050", "relation": {"cites": []}, "ISSN": ["1472-8222", "1744-7631"], "issn-type": [{"value": "1472-8222", "type": "print"}, {"value": "1744-7631", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=iett20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=iett20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T07:44:56Z", "timestamp": 1574149496622}, "reference-count": 37, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Pharmacol Exp Ther"], "published-print": {"date-parts": [[2002, 5, 1]]}, "DOI": "10.1124/jpet.301.2.536", "type": "journal-article", "created": {"date-parts": [[2003, 1, 10]], "date-time": "2003-01-10T18:35:32Z", "timestamp": 1042223732000}, "page": "536-542", "source": "Crossref", "is-referenced-by-count": 41, "title": ["Correlation of Neurokinin (NK) 1 Receptor Occupancy in Gerbil Striatum with Behavioral Effects of NK1 Antagonists"], "prefix": "10.1124", "volume": "301", "author": [{"given": "Ruth A.", "family": "Duffy", "sequence": "first", "affiliation": []}, {"given": "Geoffrey B.", "family": "Varty", "sequence": "additional", "affiliation": []}, {"given": "Cynthia A.", "family": "Morgan", "sequence": "additional", "affiliation": []}, {"given": "Jean E.", "family": "Lachowicz", "sequence": "additional", "affiliation": []}], "member": "36", "published-online": {"date-parts": [[2002, 5, 1]]}, "reference": [{"key": "2019081412083310000_301.2.536.1", "first-page": "320", "article-title": "Leakage of dl-propranolol from cerebrospinal fluid to the bloodstream in the rabbit.", "volume": "202", "author": "Anderson", "year": "1977", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2019081412083310000_301.2.536.2", "DOI": "10.1016/S0014-2999(01)00724-5", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.3", "doi-asserted-by": "crossref", "first-page": "3149", "DOI": "10.1111/j.1476-5381.1995.tb15117.x", "article-title": "The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.", "volume": "116", "author": "Beattie", "year": "1995", "journal-title": "Br J Pharmacol"}, {"key": "2019081412083310000_301.2.536.4", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1111/j.1476-5381.1991.tb12423.x", "article-title": "Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP96,345.", "volume": "104", "author": "Beresford", "year": "1991", "journal-title": "Br J Pharmacol"}, {"key": "2019081412083310000_301.2.536.5", "first-page": "1005", "article-title": "Synergistic receptor subtypes: an explanation for reserve receptors and for different intrinsic activities of full and partial agonists. Studies on the effect of substance P and its analogs on guinea pig ileum.", "volume": "42", "author": "Bergmann", "year": "1983", "journal-title": "Biomed Biochim Acta"}, {"key": "2019081412083310000_301.2.536.6", "DOI": "10.1016/S0028-3908(01)00051-X", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.7", "DOI": "10.1016/0014-2999(94)90198-8", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.8", "DOI": "10.1016/0006-2952(73)90196-2", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.9", "DOI": "10.1016/S0278-5846(00)00176-7", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.10", "DOI": "10.2165/00003495-200060030-00002", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.11", "first-page": "24", "article-title": "Differential activation of intracellular effector by two isoforms of human NK1 receptor.", "volume": "41", "author": "Fong", "year": "1992", "journal-title": "Mol Pharmacol"}, {"key": "2019081412083310000_301.2.536.12", "DOI": "10.1016/0167-0115(96)00071-7", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.13", "first-page": "438", "article-title": "Mechanisms of desensitization and resensitization of G protein coupled neurokinin 1 and neurokinin 2 receptors.", "volume": "49", "author": "Garland", "year": "1996", "journal-title": "Mol Pharmacol"}, {"key": "2019081412083310000_301.2.536.14", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1111/j.1476-5381.1982.tb08792.x", "article-title": "Relative activities of substance P-related peptides in the guinea-pig ileum and rat parotid gland, in vitro.", "volume": "75", "author": "Gater", "year": "1982", "journal-title": "Br J Pharmacol"}, {"key": "2019081412083310000_301.2.536.15", "DOI": "10.1021/jm0109558", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.16", "first-page": "774", "article-title": "LY303870, a centrally active neurokinin 1 antagonist with a long duration of action.", "volume": "280", "author": "Iyengar", "year": "1997", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2019081412083310000_301.2.536.17", "unstructured": "Kiyama H Maeno H (1998) The tachykinin system. in Atlas of Neuroactive Substances and Their Receptors in the Rat, eds Tohyama M Takatsuji K (Oxford University Press, Tokyo), pp 182\u2013191."}, {"key": "2019081412083310000_301.2.536.18", "doi-asserted-by": "crossref", "first-page": "1642", "DOI": "10.1126/science.281.5383.1640", "article-title": "Distinct mechanism for antidepressant activity by blockade of central substance P receptors.", "volume": "281", "author": "Kramer", "year": "1998", "journal-title": "Science (Wash DC)"}, {"key": "2019081412083310000_301.2.536.19", "DOI": "10.1007/BF01271569", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.20", "DOI": "10.1007/BF02245006", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.21", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1111/j.1440-1681.1983.tb00847.x", "article-title": "Leakage of catecholamines from rabbit cerebrospinal fluid following intracerebroventricular injection.", "volume": "10", "author": "Maccarrone", "year": "1983", "journal-title": "Clin Exp Pharmacol Physiol"}, {"key": "2019081412083310000_301.2.536.22", "DOI": "10.1073/pnas.92.7.2622", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.23", "DOI": "10.1074/jbc.274.23.16257", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.24", "DOI": "10.1002/(SICI)1098-1128(199607)16:4<297::AID-MED1>3.0.CO;2-S", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.25", "first-page": "900", "article-title": "Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor.", "volume": "277", "author": "McLean", "year": "1996", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2019081412083310000_301.2.536.26", "first-page": "472", "article-title": "Pharmacology of CP-99,994; a non-peptide antagonist of the tachykinin neurokinin-1 receptor.", "volume": "267", "author": "McLean", "year": "1993", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2019081412083310000_301.2.536.27", "DOI": "10.1111/j.1471-4159.1993.tb03484.x", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.28", "DOI": "10.1016/S0028-3908(00)00052-6", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.29", "DOI": "10.1016/S0165-6147(99)01396-6", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.30", "DOI": "10.1016/S0014-2999(97)85415-5", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.31", "DOI": "10.1016/0014-2999(94)90430-8", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.32", "DOI": "10.1016/S0014-2999(99)00259-9", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.33", "DOI": "10.1016/0006-8993(93)91535-Z", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.34", "DOI": "10.1016/0196-9781(82)90076-6", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.35", "DOI": "10.1016/S0006-8993(99)01976-9", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.36", "DOI": "10.1126/science.1703323", "doi-asserted-by": "publisher"}, {"key": "2019081412083310000_301.2.536.37", "DOI": "10.1146/annurev.pharmtox.41.1.877", "doi-asserted-by": "publisher"}], "container-title": ["Journal of Pharmacology and Experimental Therapeutics"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/jpet.301.2.536", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 14]], "date-time": "2019-08-14T19:57:22Z", "timestamp": 1565812642000}, "score": 23.113504, "issued": {"date-parts": [[2002, 5, 1]]}, "references-count": 37, "journal-issue": {"published-online": {"date-parts": [[2002, 5, 1]]}, "published-print": {"date-parts": [[2002, 5, 1]]}, "issue": "2"}, "alternative-id": ["10.1124/jpet.301.2.536"], "URL": "http://dx.doi.org/10.1124/jpet.301.2.536", "relation": {"cites": []}, "ISSN": ["0022-3565", "1521-0103"], "issn-type": [{"value": "0022-3565", "type": "print"}, {"value": "1521-0103", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T01:45:52Z", "timestamp": 1574300752082}, "reference-count": 0, "publisher": "SAGE Publications", "issue": "s1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Aust NZ J Psychiatry"], "published-print": {"date-parts": [[2000, 1]]}, "DOI": "10.1080/000486700598", "type": "journal-article", "created": {"date-parts": [[2007, 6, 25]], "date-time": "2007-06-25T06:59:03Z", "timestamp": 1182754743000}, "page": "A20-A20", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Therapeutic potential and challenges of the management of opioid dependency in the general practice setting"], "prefix": "10.1177", "volume": "34", "author": [{"given": "J", "family": "Duffy", "sequence": "first", "affiliation": []}], "member": "179", "container-title": ["Australian and New Zealand Journal of Psychiatry"], "language": "en", "deposited": {"date-parts": [[2011, 3, 2]], "date-time": "2011-03-02T08:27:29Z", "timestamp": 1299054449000}, "score": 22.046352, "issued": {"date-parts": [[2000, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2000, 1]]}, "issue": "s1"}, "alternative-id": ["10.1080/000486700598"], "URL": "http://dx.doi.org/10.1080/000486700598", "ISSN": ["0004-8674", "1440-1614"], "issn-type": [{"value": "0004-8674", "type": "print"}, {"value": "1440-1614", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T07:05:15Z", "timestamp": 1575270315625}, "publisher-location": "New York, NY", "reference-count": 47, "publisher": "Springer New York", "isbn-type": [{"value": "9781461478751", "type": "print"}, {"value": "9781461478768", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013]]}, "DOI": "10.1007/978-1-4614-7876-8_10", "type": "book-chapter", "created": {"date-parts": [[2013, 8, 31]], "date-time": "2013-08-31T10:50:18Z", "timestamp": 1377946218000}, "page": "273-287", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The ADAMs: New Therapeutic Targets for Cancer?"], "prefix": "10.1007", "author": [{"given": "M. J.", "family": "Duffy", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Mullooly", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Crown", "sequence": "additional", "affiliation": []}, {"given": "P. M.", "family": "McGowan", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2013, 7, 10]]}, "reference": [{"key": "10_CR00101", "doi-asserted-by": "publisher", "first-page": "258", "DOI": "10.1016/j.mam.2008.08.001", "volume": "29", "author": "DR Edwards", "year": "2008", "unstructured": "Edwards DR, Handsley MH, Pennington CJ (2008) The ADAM metalloproteinases. Mol Aspects Med 29:258\u2013289", "journal-title": "Mol Aspects Med"}, {"key": "10_CR00102", "doi-asserted-by": "publisher", "first-page": "929", "DOI": "10.1038/nrc2459", "volume": "8", "author": "G Murphy", "year": "2008", "unstructured": "Murphy G (2008) The ADAMs: signaling scissors in the tumour microenvironment. Nat Rev Cancer 8:929\u2013941", "journal-title": "Nat Rev Cancer"}, {"key": "10_CR00103", "doi-asserted-by": "publisher", "first-page": "32", "DOI": "10.1038/nrm1548", "volume": "6", "author": "CP Blobel", "year": "2005", "unstructured": "Blobel CP (2005) ADAMS: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6:32\u201343", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "10_CR00104", "doi-asserted-by": "publisher", "first-page": "1382", "DOI": "10.1093/glycob/cwr097", "volume": "21", "author": "M Tsachaki", "year": "2011", "unstructured": "Tsachaki M, Serlidaki D, Fetani A, Zarkou V, Rozani I, Ghiso J, Efthimiopoulos S (2011) Glycosylation of BRI2 on asparagine 170 is involved in its trafficking to the cell surface but not in its processing by furin or ADAM10. Glycobiology 21:1382\u20131388", "journal-title": "Glycobiology"}, {"key": "10_CR00105", "doi-asserted-by": "publisher", "first-page": "26403", "DOI": "10.1074/jbc.M110814200", "volume": "277", "author": "Y Cao", "year": "2002", "unstructured": "Cao Y, Kang Q, Zhao Z, Zolkiewska A (2002) Intracellular processing of metalloprotease disintegrin ADAM12. J Biol Chem 277:26403\u201326411", "journal-title": "J Biol Chem"}, {"key": "10_CR00106", "doi-asserted-by": "publisher", "first-page": "905", "DOI": "10.1016/j.bbagen.2008.03.004", "volume": "1780", "author": "C Escrevente", "year": "2008", "unstructured": "Escrevente C, Morais VA, Keller S, Soares CM, Altevogt P, Costa J (2008) Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme. Biochim Biophys Acta 1780:905\u2013913", "journal-title": "Biochim Biophys Acta"}, {"key": "10_CR00107", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1158/1541-7786.MCR-07-2028", "volume": "6", "author": "JL Zhong", "year": "2008", "unstructured": "Zhong JL, Poghosyan Z, Pennington CJ et al (2008) Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma. Mol Cancer Res 6:383\u2013394", "journal-title": "Mol Cancer Res"}, {"key": "10_CR00108", "doi-asserted-by": "publisher", "first-page": "11738", "DOI": "10.1074/jbc.M805894200", "volume": "284", "author": "T Tousseyn", "year": "2009", "unstructured": "Tousseyn T, Thathiah A, Jorissen E, Raemaekers T, Konietzko U, Reiss K, Maes E, Snellinx A, Serneels L, Nyabi O, Annaert W, Saftig P, Hartmann D, De Strooper B (2009) ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase. J Biol Chem 284:11738\u201311747", "journal-title": "J Biol Chem"}, {"key": "10_CR00109", "doi-asserted-by": "publisher", "first-page": "380", "DOI": "10.1016/j.it.2011.05.005", "volume": "32", "author": "J Scheller", "year": "2011", "unstructured": "Scheller J, Chalaris A, Garbers C, Rose-John S (2011) ADAM17: a molecular switch to control inflammation and tissue regeneration. Trends Immunol 32:380\u2013387", "journal-title": "Trends Immunol"}, {"issue": "43", "key": "10_CR001010", "doi-asserted-by": "publisher", "first-page": "36473", "DOI": "10.1074/jbc.M112.389114", "volume": "287", "author": "D Minond", "year": "2012", "unstructured": "Minond D, Cudic M, Bionda N, Giulianotti M, Maida L, Houghten RA, Fields GB (2012) Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates. J Biol Chem 287(43):36473\u201336487", "journal-title": "J Biol Chem"}, {"key": "10_CR001011", "doi-asserted-by": "publisher", "first-page": "5679", "DOI": "10.1128/MCB.00406-09", "volume": "29", "author": "EC Bozhulak", "year": "2009", "unstructured": "Bozhulak EC, Weinmaster G (2009) Selective use of ADAM10 and ADAM17 in activation of Notch 1 signaling. Mol Cell Biol 29:5679\u20135695", "journal-title": "Mol Cell Biol"}, {"key": "10_CR001012", "doi-asserted-by": "publisher", "first-page": "1785", "DOI": "10.1091/mbc.E08-11-1135", "volume": "20", "author": "SM Gall Le", "year": "2009", "unstructured": "Le Gall SM, Bob\u00e9 P, Reiss K, Horiuchi K, Niu XD, Lundell D, Gibb DR, Conrad D, Saftig P, Blobel CP (2009) ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. Mol Biol Cell 20:1785\u20131794", "journal-title": "Mol Biol Cell"}, {"key": "10_CR001013", "doi-asserted-by": "publisher", "first-page": "2335", "DOI": "10.1158/1078-0432.CCR-06-2092", "volume": "13", "author": "MJ Duffy", "year": "2007", "unstructured": "Duffy MJ, McKiernan E, O\u2019Donovan N, McGowan P (2007) Role of ADAMs in cancer formation and progression. Clin Cancer Res 13:2335\u20132343", "journal-title": "Clin Cancer Res"}, {"key": "10_CR001014", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1016/j.cca.2009.01.007", "volume": "403", "author": "MJ Duffy", "year": "2009", "unstructured": "Duffy MJ, McKiernan E, O\u2019Donovan N, McGowan P (2009) The role of ADAMs in disease pathophysiology. Clin Chim Acta 403:31\u201336", "journal-title": "Clin Chim Acta"}, {"key": "10_CR001015", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1186/1559-0275-8-9", "volume": "8", "author": "MJ Duffy", "year": "2011", "unstructured": "Duffy MJ, Mullooly M, O\u2019Donovan N, Sukor S, Crown J, Pierce A, McGowan PM (2011) The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer? Clin Proteomics 8:9", "journal-title": "Clin Proteomics"}, {"key": "10_CR001016", "doi-asserted-by": "publisher", "first-page": "2335", "DOI": "10.1158/1078-0432.CCR-06-2092", "volume": "13", "author": "PM McGowan", "year": "2007", "unstructured": "McGowan PM, Ryan BM, Hill AD, McDermott E, O\u2019Higgins N, Duffy MJ (2007) ADAM-17 expression in breast cancer correlates with variables of tumor progression. Clin Cancer Res 13:2335\u20132343", "journal-title": "Clin Cancer Res"}, {"key": "10_CR001017", "doi-asserted-by": "publisher", "first-page": "1075", "DOI": "10.1093/annonc/mdm609", "volume": "19", "author": "PM McGowan", "year": "2008", "unstructured": "McGowan PM, McKiernan E, Bolster F et al (2008) ADAM-17 predicts adverse outcome in patients with breast cancer. Ann Oncol 19:1075\u20131081", "journal-title": "Ann Oncol"}, {"issue": "2", "key": "10_CR001018", "doi-asserted-by": "publisher", "first-page": "362", "DOI": "10.1093/annonc/mds279", "volume": "24", "author": "PM McGowan", "year": "2013", "unstructured": "McGowan PM, Mullooly M, Caiazza F, Sukor S, Madden SF, Maguire AA, Pierce A, McDermott EW, Crown J, O\u2019Donovan N, Duffy MJ (2013) ADAM-17: a novel therapeutic target for triple negative breast cancer. Ann Oncol 24(2):362\u20139", "journal-title": "Ann Oncol"}, {"key": "10_CR001019", "doi-asserted-by": "publisher", "first-page": "906", "DOI": "10.1093/jnci/djs232", "volume": "104", "author": "S Mochizuki", "year": "2012", "unstructured": "Mochizuki S, Soejima K, Shimoda M, Abe H, Sasaki A, Okano HJ, Okano H, Okada Y (2012) Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor. J Natl Cancer Inst 104:906\u2013922", "journal-title": "J Natl Cancer Inst"}, {"key": "10_CR001020", "doi-asserted-by": "publisher", "first-page": "39", "DOI": "10.1016/j.ccr.2006.05.024", "volume": "10", "author": "S Zhou B-B", "year": "2006", "unstructured": "Zhou B-B S, Petyon M, He B et al (2006) Targeting ADAM-mediated ligand cleavage to inhibit HER2 and EGFR pathways in non-small cell lung cancer. Cancer Cell 10:39\u201350", "journal-title": "Cancer Cell"}, {"key": "10_CR001021", "doi-asserted-by": "publisher", "first-page": "1892", "DOI": "10.1158/1078-0432.CCR-06-2116", "volume": "13", "author": "JS Fridman", "year": "2007", "unstructured": "Fridman JS, Caulder E, Hansbury M et al (2007) Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer. Clin Cancer Res 13:1892\u20131902", "journal-title": "Clin Cancer Res"}, {"key": "10_CR001022", "unstructured": "Fridman JS, Scherle PA, Liu X et al (2007) Preclinical characterization of INCB7839, a potent and selective inhibitor of ErbB ligand and HER2 receptor shedding: inhibition of ADAM10 and ADAM17 for the treatment of breast cancer. Breast Cancer Res Treat 106 (Supp 1):S82"}, {"key": "10_CR001023", "unstructured": "Infante J, Burris HA, Lewis N et al (2007) A multicenter phase Ib study of the safety, pharmacokinetics, biological activity and clinical efficacy of INCB7839, a potent and selective inhibitor of ADAM10 and ADAM17. Breast Cancer Res Treat 106 (Supp1):S269"}, {"key": "10_CR001024", "doi-asserted-by": "publisher", "first-page": "1845", "DOI": "10.1016/j.intimp.2004.08.003", "volume": "4", "author": "Y Zhang", "year": "2004", "unstructured": "Zhang Y, Hegen M, Xu J et al (2004) Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzyme. Int Immunopharmacol 4:1845\u20131857", "journal-title": "Int Immunopharmacol"}, {"key": "10_CR001025", "doi-asserted-by": "publisher", "first-page": "7083", "DOI": "10.1158/0008-5472.CAN-08-0739", "volume": "68", "author": "L Witters", "year": "2008", "unstructured": "Witters L, Scherle P, Friedman S et al (2008) Synergistic inhibition with a dual epidermal growth factor receptor/HER-2/neu tyrosine kinase inhibitor and a disintegrin and metalloprotease inhibitor. Cancer Res 68:7083\u20137089", "journal-title": "Cancer Res"}, {"key": "10_CR001026", "doi-asserted-by": "publisher", "first-page": "1186", "DOI": "10.1182/blood-2002-12-3775", "volume": "102", "author": "C Hundhausen", "year": "2003", "unstructured": "Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, Kallen KJ, Rose-John S, Ludwig A (2003) The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102:1186\u20131195", "journal-title": "Blood"}, {"key": "10_CR001027", "unstructured": "Mullooly M, McGowan PM, Sukor S et al (2012) ADAM10: A new player in breast cancer progression. American Association for Cancer Research annual meeting, Chicago, abstract no 1845"}, {"key": "10_CR001028", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.2174/1386207053258488", "volume": "8", "author": "A Ludwig", "year": "2005", "unstructured": "Ludwig A, Hundhausen C, Lambert MH, Broadway N, Andrews RC, Bickett DM, Leesnitzer MA, Becherer JD (2005) Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen 8:161\u2013171", "journal-title": "Comb Chem High Throughput Screen"}, {"key": "10_CR001029", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1038/nm0102-35", "volume": "8", "author": "M Asakura", "year": "2002", "unstructured": "Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, Asanuma H, Sanada S, Matsumura Y, Takeda H, Beppu S, Tada M, Hori M, Higashiyama S (2002) Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 8:35\u201340", "journal-title": "Nat Med"}, {"key": "10_CR001030", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.2174/138161207779313551", "volume": "13", "author": "B Fingleton", "year": "2007", "unstructured": "Fingleton B (2007) Matrix metalloproteinases as valid clinical targets. Curr Pharm Des 13:333\u2013346", "journal-title": "Curr Pharm Des"}, {"key": "10_CR001031", "doi-asserted-by": "publisher", "first-page": "6642", "DOI": "10.1038/sj.onc.1204097", "volume": "19", "author": "S Zucker", "year": "2000", "unstructured": "Zucker S, Cao J, Chen W-T (2000) Critical appraisal of the use of matrix metalloproteinases inhibitors in cancer treatment. Oncogene 19:6642\u20136650", "journal-title": "Oncogene"}, {"key": "10_CR001032", "doi-asserted-by": "publisher", "first-page": "233", "DOI": "10.1186/gb-2011-12-11-233", "volume": "11", "author": "G Murphy", "year": "2011", "unstructured": "Murphy G (2011) Tissue inhibitors of metalloproteinases. Genome Biol 11:233", "journal-title": "Genome Biol"}, {"key": "10_CR001033", "doi-asserted-by": "publisher", "first-page": "ra34", "DOI": "10.1126/scisignal.2002689", "volume": "5", "author": "P Xu", "year": "2012", "unstructured": "Xu P, Liu J, Sakaki-Yumoto M, Derynck R (2012) TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association. Sci Signal 5:ra34", "journal-title": "Sci Signal"}, {"key": "10_CR001034", "doi-asserted-by": "publisher", "first-page": "433", "DOI": "10.1042/BJ20071430", "volume": "411", "author": "M Rapti", "year": "2008", "unstructured": "Rapti M, Atkinson SJ, Lee MH, Trim A, Moss M, Murphy G (2008) The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition. Biochem J 411:433\u2013439", "journal-title": "Biochem J"}, {"key": "10_CR001035", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1042/BJ20100649", "volume": "430", "author": "M Kveiborg", "year": "2010", "unstructured": "Kveiborg M, Jacobsen J, Lee MH, Nagase H, Wewer UM, Murphy G (2010) Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2). Biochem J 430:79\u201386", "journal-title": "Biochem J"}, {"key": "10_CR001036", "doi-asserted-by": "publisher", "first-page": "35712", "DOI": "10.1074/jbc.M703231200", "volume": "282", "author": "ML Moss", "year": "2007", "unstructured": "Moss ML, Bomar M, Liu Q et al (2007) The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J Biol Chem 282:35712\u201335721", "journal-title": "J Biol Chem"}, {"key": "10_CR001037", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1007/s00432-004-0619-y", "volume": "131", "author": "U Lendeckel", "year": "2005", "unstructured": "Lendeckel U, Kohl J, Arndt M et al (2005) Increased expression of ADAM family members in human breast cancer and breast cancer cell lines. J Cancer Res Clin Oncol 131:41\u201348", "journal-title": "J Cancer Res Clin Oncol"}, {"issue": "14", "key": "10_CR001038", "doi-asserted-by": "publisher", "first-page": "5578", "DOI": "10.1073/pnas.1017067108", "volume": "108", "author": "CJ Tape", "year": "2011", "unstructured": "Tape CJ, Willems SH, Dombernowsky SL, Stanley PL, Fogarasi M, Ouwehand W, McCafferty J, Murphy G (2011) Cross-domain inhibition of TACE ectodomain. Proc Natl Acad Sci U S A 108(14):5578\u20135583", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10_CR001039", "doi-asserted-by": "publisher", "first-page": "e40597", "DOI": "10.1371/journal.pone.0040597", "volume": "7", "author": "FM Richards", "year": "2012", "unstructured": "Richards FM, Tape CJ, Jodrell DI, Murphy G (2012) Anti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model in vivo. PLoS One 7:e40597", "journal-title": "PLoS One"}, {"key": "10_CR001040", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1042/BJ20120433", "volume": "445", "author": "K Yamamoto", "year": "2012", "unstructured": "Yamamoto K, Trad A, Baumgart A, H\u00fcske L, Lorenzen I, Chalaris A, Gr\u00f6tzinger J, Dechow T, Scheller J, Rose-John S (2012) A novel bispecific single-chain antibody for ADAM17 and CD3 induces T-cell-mediated lysis of prostate cancer cells. Biochem J 445:135\u2013144", "journal-title": "Biochem J"}, {"issue": "3", "key": "10_CR001041", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1007/s00262-012-1346-x", "volume": "162", "author": "A Trad", "year": "2012", "unstructured": "Trad A, Hansen HP, Shomali M, Peipp M, Klausz K, Hedemann N, Yamamoto K, Mauermann A, Desel C, Lorenzen I, Lemke H, Rose-John S, Gr\u00f6tzinger J (2012) ADAM17-overexpressing breast cancer cells selectively targeted by antibody-toxin conjugates. Cancer Immunol Immunother 162(3):411\u201321", "journal-title": "Cancer Immunol Immunother"}, {"key": "10_CR001042", "doi-asserted-by": "publisher", "first-page": "1105", "DOI": "10.1084/jem.20112258", "volume": "209", "author": "CW Franzke", "year": "2012", "unstructured": "Franzke CW, Cobzaru C, Triantafyllopoulou A, L\u00f6ffek S, Horiuchi K, Threadgill DW, Kurz T, van Rooijen N, Bruckner-Tuderman L, Blobel CP (2012) Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. J Exp Med 209:1105\u20131119", "journal-title": "J Exp Med"}, {"key": "10_CR001043", "doi-asserted-by": "publisher", "first-page": "2898", "DOI": "10.1172/JCI63103", "volume": "122", "author": "J Guinea-Viniegra", "year": "2012", "unstructured": "Guinea-Viniegra J, Zenz R, Scheuch H, Jim\u00e9nez M, Bakiri L, Petzelbauer P, Wagner EF (2012) Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. J Clin Invest 122:2898\u20132910", "journal-title": "J Clin Invest"}, {"key": "10_CR001044", "doi-asserted-by": "publisher", "first-page": "1617", "DOI": "10.1084/jem.20092366", "volume": "207", "author": "A Chalaris", "year": "2010", "unstructured": "Chalaris A, Adam N, Sina C, Rosenstiel P, Lehmann-Koch J, Schirmacher P, Hartmann D, Cichy J, Gavrilova O, Schreiber S, Jostock T, Matthews V, H\u00e4sler R, Becker C, Neurath MF, Reiss K, Saftig P, Scheller J, Rose-John S (2010) Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J Exp Med 207:1617\u20131624", "journal-title": "J Exp Med"}, {"issue": "16", "key": "10_CR001045", "doi-asserted-by": "publisher", "first-page": "1502", "DOI": "10.1056/NEJMoa1100721", "volume": "365", "author": "DC Blaydon", "year": "2011", "unstructured": "Blaydon DC, Biancheri P, Di WL, Plagnol V, Cabral RM, Brooke MA, van Heel DA, Ruschendorf F, Toynbee M, Walne A, O\u2019Toole EA, Martin JE, Lindley K, Vulliamy T, Abrams DJ, MacDonald TT, Harper JI, Kelsell DP (2011) Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med 365(16):1502\u20131508", "journal-title": "N Engl J Med"}, {"key": "10_CR001046", "doi-asserted-by": "publisher", "first-page": "5114", "DOI": "10.4049/jimmunol.1102172", "volume": "187", "author": "NS Chaimowitz", "year": "2011", "unstructured": "Chaimowitz NS, Martin RK, Cichy J, Gibb DR, Patil P, Kang DJ, Farnsworth J, Butcher EC, McCright B, Conrad DH (2011) A disintegrin and metalloproteinase 10 regulates antibody production and maintenance of lymphoid architecture. J Immunol 187:5114\u20135122", "journal-title": "J Immunol"}, {"issue": "Supp 24", "key": "10_CR001047", "doi-asserted-by": "publisher", "first-page": "5056", "DOI": "10.1158/0008-5472.SABCS-09-5056", "volume": "69", "author": "S Friedman", "year": "2009", "unstructured": "Friedman S, Levy R, Garrett W, Doval DC, Bondarde S, Sahoo TP, Lokanatha D, Julka PK, Shenoy K, Nagarkar R, Bhattacharyya GS, Kumar K, Nag S, Mohan PR, Narang NR, Raghunadharao D, Walia M, Yao W, Li J, Emm T, Yeleswaram S, Scherle P, Newton R (2009) Clinical benefit of INCB7839, a potent and selective inhibitor of ADAM10 and ADAM17, in combination with trastuzumab in metastatic HER2 positive breast cancer patients. Cancer Res 69(Supp 24):5056", "journal-title": "Cancer Res"}], "container-title": ["Cancer Targeted Drug Delivery"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4614-7876-8_10", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 17]], "date-time": "2019-05-17T01:05:56Z", "timestamp": 1558055156000}, "score": 21.463871, "issued": {"date-parts": [[2013]]}, "ISBN": ["9781461478751", "9781461478768"], "references-count": 47, "URL": "http://dx.doi.org/10.1007/978-1-4614-7876-8_10", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T23:13:23Z", "timestamp": 1575155603541}, "reference-count": 1, "publisher": "Wiley", "issue": "27", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3710, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["ChemInform"], "published-print": {"date-parts": [[2005, 7, 5]]}, "DOI": "10.1002/chin.200527109", "type": "journal-article", "created": {"date-parts": [[2005, 6, 16]], "date-time": "2005-06-16T13:49:10Z", "timestamp": 1118929750000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Discovery and Investigation of a Novel Class of Thiophene-Derived Antagonists of the Human Glucagon Receptor."], "prefix": "10.1002", "volume": "36", "author": [{"given": "Joseph L.", "family": "Duffy", "sequence": "first", "affiliation": []}, {"given": "et al.", "family": "et al.", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/chin.200527109-BIB1", "author": "Duffy", "volume": "15", "first-page": "1401", "year": "2005", "journal-title": "Bioorg. Med. Chem. Lett.", "DOI": "10.1016/j.bmcl.2005.01.003", "doi-asserted-by": "crossref"}], "container-title": ["ChemInform"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.200527109", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/chin.200527109", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 26]], "date-time": "2019-02-26T04:30:26Z", "timestamp": 1551155426000}, "score": 20.93108, "issued": {"date-parts": [[2005, 7, 5]]}, "references-count": 1, "journal-issue": {"published-print": {"date-parts": [[2005, 7, 5]]}, "issue": "27"}, "URL": "http://dx.doi.org/10.1002/chin.200527109", "relation": {"cites": []}, "ISSN": ["0931-7597", "1522-2667"], "issn-type": [{"value": "0931-7597", "type": "print"}, {"value": "1522-2667", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T14:01:00Z", "timestamp": 1574863260192}, "reference-count": 32, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["SHOCK"], "published-print": {"date-parts": [[2019, 7]]}, "DOI": "10.1097/shk.0000000000001248", "type": "journal-article", "created": {"date-parts": [[2018, 8, 8]], "date-time": "2018-08-08T23:33:50Z", "timestamp": 1533771230000}, "page": "61-66", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Neurokinin-1 Receptor Deficiency Improves Survival in Murine Polymicrobial Sepsis Through Multiple Mechanisms in Aged Mice"], "prefix": "10.1097", "volume": "52", "author": [{"given": "Juan R.", "family": "Mella", "sequence": "first", "affiliation": []}, {"given": "Arthur F.", "family": "Stucchi", "sequence": "additional", "affiliation": []}, {"given": "Elizabeth R.", "family": "Duffy", "sequence": "additional", "affiliation": []}, {"given": "Daniel G.", "family": "Remick", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["SHOCK"], "language": "en", "link": [{"URL": "http://journals.lww.com/shockjournal/Fulltext/10.1097/SHK.0000000000001248", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 23]], "date-time": "2019-10-23T19:47:28Z", "timestamp": 1571860048000}, "score": 20.442215, "subtitle": [""], "issued": {"date-parts": [[2019, 7]]}, "references-count": 32, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.1097/shk.0000000000001248", "ISSN": ["1073-2322"], "issn-type": [{"value": "1073-2322", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T12:54:15Z", "timestamp": 1575377655728}, "reference-count": 90, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2019, 1, 1]], "date-time": "2019-01-01T00:00:00Z", "timestamp": 1546300800000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/501100003725", "name": "National Research Foundation of Korea", "doi-asserted-by": "crossref", "award": ["2017R1A5A2015385", "No. 2017R1A2A1A05001225"]}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Arch. Pharm. Res."], "published-print": {"date-parts": [[2019, 1]]}, "DOI": "10.1007/s12272-018-01107-8", "type": "journal-article", "created": {"date-parts": [[2019, 1, 4]], "date-time": "2019-01-04T15:09:39Z", "timestamp": 1546614579000}, "page": "76-87", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Post-translational modification of the death receptor complex as a potential therapeutic target in cancer"], "prefix": "10.1007", "volume": "42", "author": [{"given": "Kidong", "family": "Kang", "sequence": "first", "affiliation": []}, {"given": "So-Ra", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "Xuezhe", "family": "Piao", "sequence": "additional", "affiliation": []}, {"given": "Gang Min", "family": "Hur", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2019, 1, 4]]}, "reference": [{"key": "1107_CR1", "doi-asserted-by": "publisher", "first-page": "e208", "DOI": "10.1038/cddis.2011.82", "volume": "2", "author": "JP Alameda", "year": "2011", "unstructured": "Alameda JP, Fern\u00e1ndez-Ace\u00f1ero MJ, Moreno-Maldonado R, Navarro M, Quintana R, Page A, Ram\u00edrez A, Bravo A, Casanova ML (2011) CYLD\u00a0regulates keratinocyte differentiation and skin cancer progression in humans. Cell Death Dis. 2:e208", "journal-title": "Cell Death Dis."}, {"key": "1107_CR2", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1016/j.molmed.2017.11.002", "volume": "24", "author": "A Annibaldi", "year": "2018", "unstructured": "Annibaldi A, Meier P (2018) Checkpoints in TNF-induced cell death: implications in inflammation and cancer. Trends Mol Med 24:49\u201365", "journal-title": "Trends Mol Med"}, {"key": "1107_CR3", "doi-asserted-by": "publisher", "first-page": "1305", "DOI": "10.1126/science.281.5381.1305", "volume": "281", "author": "A Ashkenazi", "year": "1998", "unstructured": "Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305\u20131308", "journal-title": "Science"}, {"key": "1107_CR4", "doi-asserted-by": "publisher", "first-page": "210", "DOI": "10.1016/j.biocel.2009.11.015", "volume": "42", "author": "M Bagnoli", "year": "2010", "unstructured": "Bagnoli M, Canevari S, Mezzanzanica D (2010) Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer. Int J Biochem Cell Biol 42:210\u2013213", "journal-title": "Int J Biochem Cell Biol"}, {"key": "1107_CR5", "doi-asserted-by": "publisher", "first-page": "3261", "DOI": "10.1038/sj.onc.1202568", "volume": "17", "author": "SJ Baker", "year": "1998", "unstructured": "Baker SJ, Reddy EP (1998) Modulation of life and death by the TNF receptor superfamily. Oncogene 17:3261\u20133270", "journal-title": "Oncogene"}, {"key": "1107_CR6", "doi-asserted-by": "publisher", "first-page": "361", "DOI": "10.1038/nrc2628", "volume": "9", "author": "F Balkwill", "year": "2009", "unstructured": "Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9:361\u2013371", "journal-title": "Nat Rev Cancer"}, {"key": "1107_CR7", "doi-asserted-by": "publisher", "first-page": "13031", "DOI": "10.1074/jbc.M800549200", "volume": "283", "author": "S Barbero", "year": "2008", "unstructured": "Barbero S, Baril\u00e0 D, Mielgo A, Stagni V, Clair K, Stupack D (2008) Identification of a critical tyrosine residue in caspase 8 that promotes cell migration. J Biol Chem 283:13031\u201313034", "journal-title": "J Biol Chem"}, {"key": "1107_CR8", "doi-asserted-by": "publisher", "first-page": "689", "DOI": "10.1016/j.molcel.2008.05.014", "volume": "30", "author": "MJ Bertrand", "year": "2008", "unstructured": "Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ, Barker PA (2008) cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 30:689\u2013700", "journal-title": "Mol Cell"}, {"key": "1107_CR9", "doi-asserted-by": "publisher", "first-page": "1901", "DOI": "10.1128/MCB.01416-12", "volume": "33", "author": "K Blackwell", "year": "2013", "unstructured": "Blackwell K, Zhang L, Workman LM, Ting AT, Iwai K, Habelhah H (2013) Two coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and delayed I\u03baB kinase activation. Mol Cell Biol 33:1901\u20131915", "journal-title": "Mol Cell Biol"}, {"key": "1107_CR87", "doi-asserted-by": "publisher", "first-page": "1178", "DOI": "10.1038/ni.2457", "volume": "13", "author": "B Boisson", "year": "2012", "unstructured": "Boisson B, Laplantine E, Prando C, Giliani S, Israelsson E, Xu Z, Abhyankar A, Isra\u00ebl L, Trevejo-Nunez G, Bogunovic D, Cepika A-M, MacDuff D, Chrabieh M, Hubeau M, Bajolle F, Debr\u00e9 M, Mazzolari E, Vairo D, Agou F, Virgin HW, Bossuyt X, Rambaud C, Facchetti F, Bonnet D, Quartier P, Fournet J-C, Pascual V, Chaussabel D, Notarangelo LD, Puel A, Isra\u00ebl A, Casanova J-L, Picard C (2012) Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol 13(12):1178\u20131186", "journal-title": "Nat Immunol"}, {"key": "1107_CR10", "doi-asserted-by": "publisher", "first-page": "362", "DOI": "10.1038/nri3834", "volume": "15", "author": "D Brenner", "year": "2015", "unstructured": "Brenner D, Blaser H, Mak TW (2015) Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol 15:362\u2013374", "journal-title": "Nat Rev Immunol"}, {"key": "1107_CR11", "doi-asserted-by": "publisher", "first-page": "1634", "DOI": "10.1126/science.1071924", "volume": "296", "author": "G Chen", "year": "2002", "unstructured": "Chen G, Goeddel DV (2002) TNF-R1 signaling: a beautiful pathway. Science 296:1634\u20131635", "journal-title": "Science"}, {"key": "1107_CR12", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1016/j.molcel.2009.01.014", "volume": "33", "author": "ZJ Chen", "year": "2009", "unstructured": "Chen ZJ, Sun LJ (2009) Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33:275\u2013286", "journal-title": "Mol Cell"}, {"key": "1107_CR88", "doi-asserted-by": "publisher", "first-page": "505", "DOI": "10.1016/0092-8674(95)90071-3", "volume": "81", "author": "AM Chinnaiyan", "year": "1995", "unstructured": "Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis. Cell 81(4):505\u2013512", "journal-title": "Cell"}, {"key": "1107_CR13", "doi-asserted-by": "publisher", "first-page": "1112", "DOI": "10.1016/j.cell.2009.05.037", "volume": "137", "author": "YS Cho", "year": "2009", "unstructured": "Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FK (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137:1112\u20131123", "journal-title": "Cell"}, {"key": "1107_CR14", "doi-asserted-by": "publisher", "first-page": "90", "DOI": "10.1038/nature13608", "volume": "513", "author": "M Dannappel", "year": "2014", "unstructured": "Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, Wachsmuth L, Eftychi C, Lin J, Corona T, Hermance N, Zelic M, Kirsch P, Basic M, Bleich A, Kelliher M, Pasparakis M (2014) RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513:90\u201394", "journal-title": "Nature"}, {"key": "1107_CR15", "doi-asserted-by": "publisher", "first-page": "e0127546", "DOI": "10.1371/journal.pone.0127546", "volume": "10", "author": "J Melo De", "year": "2015", "unstructured": "De Melo J, Tang D (2015) Elevation of SIPL1 (SHARPIN) increases breast cancer risk. PLoS ONE 10:e0127546", "journal-title": "PLoS ONE"}, {"key": "1107_CR16", "doi-asserted-by": "publisher", "first-page": "313", "DOI": "10.1038/nchembio.83", "volume": "4", "author": "A Degterev", "year": "2008", "unstructured": "Degterev A, Hitomi J, Germscheid M, Ch\u2019en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4:313\u2013321", "journal-title": "Nat Chem Biol"}, {"key": "1107_CR17", "doi-asserted-by": "publisher", "first-page": "366", "DOI": "10.1038/cdd.2012.133", "volume": "20", "author": "A Degterev", "year": "2013", "unstructured": "Degterev A, Maki JL, Yuan Y (2013) Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ 20:366", "journal-title": "Cell Death Differ"}, {"key": "1107_CR18", "doi-asserted-by": "publisher", "first-page": "1381", "DOI": "10.1038/cdd.2013.94", "volume": "20", "author": "Y Dondelinger", "year": "2013", "unstructured": "Dondelinger Y, Aguileta MA, Goossens V, Dubuisson C, Grootjans S, Dejardin E, Vandenabeele P, Bertrand MJ (2013) RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ 20:1381\u20131392", "journal-title": "Cell Death Differ"}, {"key": "1107_CR19", "doi-asserted-by": "publisher", "first-page": "63", "DOI": "10.1016/j.molcel.2015.07.032", "volume": "60", "author": "Y Dondelinger", "year": "2015", "unstructured": "Dondelinger Y, Jouan-Lanhouet S, Divert T, Theatre E, Bertin J, Gough PJ, Giansanti P, Heck AJ, Dejardin E, Vandenabeele P, Bertrand MJ (2015) NF-\u03baB-independent role of IKK\u03b1/IKK\u03b2 in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling. Mol Cell 60:63\u201376", "journal-title": "Mol Cell"}, {"key": "1107_CR20", "doi-asserted-by": "publisher", "first-page": "1237", "DOI": "10.1038/ncb3608", "volume": "19", "author": "Y Dondelinger", "year": "2017", "unstructured": "Dondelinger Y, Delanghe T, Rojas-Rivera D, Priem D, Delvaeye T, Bruggeman I, Van Herreweghe F, Vandenabeele P, Bertrand MJM (2017) MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. Nat Cell Biol 19:1237\u20131247", "journal-title": "Nat Cell Biol"}, {"key": "1107_CR21", "doi-asserted-by": "publisher", "first-page": "4198", "DOI": "10.1038/emboj.2010.300", "volume": "29", "author": "JN Dynek", "year": "2010", "unstructured": "Dynek JN, Goncharov T, Dueber EC, Fedorova AV, Izrael-Tomasevic A, Phu L, Helgason E, Fairbrother WJ, Deshayes K, Kirkpatrick DS, Vucic D (2010) c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J 29:4198\u20134209", "journal-title": "EMBO J"}, {"key": "1107_CR22", "doi-asserted-by": "publisher", "first-page": "58", "DOI": "10.1038/s41556-017-0003-1", "volume": "20", "author": "SA Dziedzic", "year": "2018", "unstructured": "Dziedzic SA, Su Z, Jean Barrett V, Najafov A, Mookhtiar AK, Amin P, Pan H, Sun L, Zhu H, Ma A, Abbott DW, Yuan J (2018) ABIN-1 regulates RIPK1 activation by linking Met1 ubiquitylation with Lys63 deubiquitylation in TNF-RSC. Nat Cell Biol 20:58\u201368", "journal-title": "Nat Cell Biol"}, {"issue": "2", "key": "1107_CR89", "doi-asserted-by": "publisher", "first-page": "245", "DOI": "10.1016/j.molcel.2006.03.026", "volume": "22", "author": "C-K Ea", "year": "2006", "unstructured": "Ea C-K, Deng L, Xia Z-P, Pineda G, Chen ZJ (2006) Activation of IKK by TNF\u03b1 requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22(2):245\u2013257", "journal-title": "Mol Cell"}, {"key": "1107_CR23", "doi-asserted-by": "publisher", "first-page": "449", "DOI": "10.1016/j.molcel.2011.06.011", "volume": "43", "author": "M Feoktistova", "year": "2011", "unstructured": "Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M, Cain K, MacFarlane M, H\u00e4cker G, Leverkus M (2011) cIAPs block ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 43:449\u2013463", "journal-title": "Mol Cell"}, {"key": "1107_CR24", "first-page": "54809", "volume": "8", "author": "T Fu", "year": "2017", "unstructured": "Fu T, Lv X, Kong Q, Yuan CA (2017) novel SHARPIN-PRMT5-H3R2me1 axis is essential for lung cancer cell invasion. Oncotarget 8:54809\u201354820", "journal-title": "Oncotarget"}, {"key": "1107_CR25", "doi-asserted-by": "publisher", "first-page": "5030", "DOI": "10.1158/1078-0432.CCR-15-0365", "volume": "21", "author": "S Fulda", "year": "2015", "unstructured": "Fulda S (2015) Promises and challenges of smac mimetics as cancer therapeutics. Clin Cancer Res 21:5030\u20135036", "journal-title": "Clin Cancer Res"}, {"key": "1107_CR26", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1038/s41467-017-00406-w", "volume": "8", "author": "J Geng", "year": "2017", "unstructured": "Geng J, Ito Y, Shi L, Amin P, Chu J, Ouchida AT, Mookhtiar AK, Zhao H, Xu D, Shan B, Najafov A, Gao G, Akira S, Yuan J (2017) Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat Commun 8:359", "journal-title": "Nat Commun"}, {"key": "1107_CR27", "doi-asserted-by": "publisher", "first-page": "13282", "DOI": "10.1074/jbc.M110.216226", "volume": "286", "author": "IE Gentle", "year": "2011", "unstructured": "Gentle IE, Wong WW, Evans JM, Bankovacki A, Cook WD, Khan NR, Nachbur U, Rickard J, Anderton H, Moulin M, Lluis JM, Moujalled DM, Silke J, Vaux DL (2011) In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8. J Biol Chem 286:13282\u201313291", "journal-title": "J Biol Chem"}, {"key": "1107_CR28", "doi-asserted-by": "publisher", "first-page": "1265", "DOI": "10.1158/0008-5472.CAN-09-2674", "volume": "70", "author": "N Gustafsson", "year": "2010", "unstructured": "Gustafsson N, Zhao C, Gustafsson JA, Dahlman-Wright K (2010) RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1. Cancer Res 70:1265\u20131274", "journal-title": "Cancer Res"}, {"key": "1107_CR29", "doi-asserted-by": "publisher", "first-page": "831", "DOI": "10.1016/j.molcel.2009.10.013", "volume": "36", "author": "TL Haas", "year": "2009", "unstructured": "Haas TL, Emmerich CH, Gerlach B, Schmukle AC, Cordier SM, Rieser E, Feltham R, Vince J, Warnken U, Wenger T, Koschny R, Komander D, Silke J, Walczak H (2009) Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell 36:831\u2013844", "journal-title": "Mol Cell"}, {"key": "1107_CR30", "first-page": "re13", "volume": "357", "author": "H H\u00e4cker", "year": "2006", "unstructured": "H\u00e4cker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 357:re13", "journal-title": "Sci STKE"}, {"key": "1107_CR31", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1093/carcin/bgl081", "volume": "28", "author": "C Hellerbrand", "year": "2007", "unstructured": "Hellerbrand C, Bumes E, Bataille F, Dietmaier W, Massoumi R, Bosserhoff AK (2007) Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis 28:21\u201327", "journal-title": "Carcinogenesis"}, {"key": "1107_CR32", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1016/S0092-8674(00)80984-8", "volume": "84", "author": "H Hsu", "year": "1996", "unstructured": "Hsu H, Shu HB, Pan MG, Goeddel DV (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299\u2013308", "journal-title": "Cell"}, {"key": "1107_CR33", "doi-asserted-by": "publisher", "first-page": "834", "DOI": "10.1016/j.molcel.2016.02.023", "volume": "61", "author": "MA Hughes", "year": "2016", "unstructured": "Hughes MA, Powley IR, Jukes-Jones R, Horn S, Feoktistova M, Fairall L, Schwabe JW, Leverkus M, Cain K, MacFarlane M (2016) Co-operative and hierarchical binding of c-FLIP and caspase-8: a unified model defines how c-FLIP isoforms differentially control cell fate. Mol Cell 61:834\u2013849", "journal-title": "Mol Cell"}, {"key": "1107_CR34", "doi-asserted-by": "publisher", "first-page": "637", "DOI": "10.1038/nature09814", "volume": "471", "author": "F Ikeda", "year": "2011", "unstructured": "Ikeda F, Deribe YL, Sk\u00e5nland SS, Stieglitz B, Grabbe C, Franz-Wachtel M, van Wijk SJ, Goswami P, Nagy V, Terzic J, Tokunaga F, Androulidaki A, Nakagawa T, Pasparakis M, Iwai K, Sundberg JP, Schaefer L, Rittinger K, Macek B, Dikic I (2011) SHARPIN forms a linear ubiquitin ligase complex regulating NF-\u03baB activity and apoptosis. Nature 471:637\u2013641", "journal-title": "Nature"}, {"key": "1107_CR35", "doi-asserted-by": "publisher", "first-page": "698", "DOI": "10.1016/j.molcel.2017.05.003", "volume": "6", "author": "I Jaco", "year": "2017", "unstructured": "Jaco I, Annibaldi A, Lalaoui N, Wilson R, Tenev T, Laurien L, Kim C, Jamal K, Wicky John S, Liccardi G, Chau D, Murphy JM, Brumatti G, Feltham R, Pasparakis M, Silke J, Meier P (2017) MK2 phosphorylates RIPK1 to prevent TNF-induced cell death. Mol Cell 6:698\u2013710", "journal-title": "Mol Cell"}, {"key": "1107_CR36", "doi-asserted-by": "publisher", "first-page": "3291", "DOI": "10.1182/blood-2007-02-075069", "volume": "110", "author": "MW Jenner", "year": "2007", "unstructured": "Jenner MW, Leone PE, Walker BA, Ross FM, Johnson DC, Gonzalez D, Chiecchio L, Dachs Cabanas E, Dagrada GP, Nightingale M, Protheroe RK, Stockley D, Else M, Dickens NJ, Cross NC, Davies FE, Morgan GJ (2007) Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma. Blood 110:3291\u20133300", "journal-title": "Blood"}, {"key": "1107_CR37", "doi-asserted-by": "publisher", "first-page": "535", "DOI": "10.1016/j.molcel.2004.08.008", "volume": "15", "author": "A Kanayama", "year": "2004", "unstructured": "Kanayama A, Seth RB, Sun L, Ea CK, Hong M, Shaito A, Chiu YH, Deng L, Chen ZJ (2004) TAB 2 and TAB 3 activate the NF-\u03baB pathway through binding to polyubiquitin chains. Mol Cell 15:535\u2013548", "journal-title": "Mol Cell"}, {"key": "1107_CR38", "doi-asserted-by": "publisher", "first-page": "221", "DOI": "10.1038/ni0302-221", "volume": "3", "author": "M Karin", "year": "2002", "unstructured": "Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3:221\u2013227", "journal-title": "Nat Immunol"}, {"key": "1107_CR39", "doi-asserted-by": "publisher", "first-page": "712", "DOI": "10.1038/nature07969", "volume": "459", "author": "M Kato", "year": "2009", "unstructured": "Kato M, Sanada M, Kato I, Sato Y, Takita J, Takeuchi K, Niwa A, Chen Y, Nakazaki K, Nomoto J, Asakura Y, Muto S, Tamura A, Iio M, Akatsuka Y, Hayashi Y, Mori H, Igarashi T, Kurokawa M, Chiba S, Mori S, Ishikawa Y, Okamoto K, TobinaiK Nakagama H, Nakahata T, Yoshino T, Kobayashi Y, Ogawa S (2009) Frequent inactivation of A20 in B-cell lymphomas. Nature 459:712\u2013716", "journal-title": "Nature"}, {"key": "1107_CR40", "doi-asserted-by": "publisher", "first-page": "16631", "DOI": "10.1074/jbc.M110.148585", "volume": "286", "author": "SM Kavuri", "year": "2011", "unstructured": "Kavuri SM, Geserick P, Berg D, Dimitrova DP, Feoktistova M, Siegmund D, Gollnick H, Neumann M, Wajant H, Leverkus M (2011) Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex. J Biol Chem 286:16631\u201316646", "journal-title": "J Biol Chem"}, {"key": "1107_CR41", "doi-asserted-by": "publisher", "first-page": "541", "DOI": "10.1016/j.tibs.2011.06.006", "volume": "36", "author": "K Kersse", "year": "2011", "unstructured": "Kersse K, Verspurten J, Vanden Berghe T, Vandenabeele P (2011) The death-fold superfamily of homotypic interaction motifs. Trends Biochem Sci 36:541\u2013552", "journal-title": "Trends Biochem Sci"}, {"key": "1107_CR90", "doi-asserted-by": "publisher", "first-page": "e0197183", "DOI": "10.1371/journal.pone.0197183", "volume": "13", "author": "A Kharman-Biz", "year": "2018", "unstructured": "Kharman-Biz A, Gao H, Ghiasvand R, Haldosen L-A, Zendehdel K, Ahmad A (2018) Expression of the three components of linear ubiquitin assembly complex in breast cancer. PLOS ONE 13(5):e0197183", "journal-title": "PLOS ONE"}, {"key": "1107_CR42", "doi-asserted-by": "publisher", "first-page": "5579", "DOI": "10.1002/j.1460-2075.1995.tb00245.x", "volume": "14", "author": "FC Kischkel", "year": "1995", "unstructured": "Kischkel FC, Hellbardt S, Behrmann I (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579\u20135588", "journal-title": "EMBO J"}, {"key": "1107_CR43", "doi-asserted-by": "publisher", "first-page": "2251", "DOI": "10.1038/onc.2014.159", "volume": "34", "author": "T Kobayashi", "year": "2015", "unstructured": "Kobayashi T, Masoumi KC, Massoumi R (2015) Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells. Oncogene 34:2251\u20132260", "journal-title": "Oncogene"}, {"key": "1107_CR44", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1146/annurev-biochem-060310-170328", "volume": "81", "author": "D Komander", "year": "2012", "unstructured": "Komander D, Rape M (2012) The ubiquitin code. Annu Rev Biochem 81:203\u2013229", "journal-title": "Annu Rev Biochem"}, {"key": "1107_CR45", "doi-asserted-by": "publisher", "first-page": "145", "DOI": "10.1016/j.ccell.2016.01.006", "volume": "29", "author": "N Lalaoui", "year": "2016", "unstructured": "Lalaoui N, H\u00e4nggi K, Brumatti G, Chau D, Nguyen NY, Vasilikos L, DA SpilgiesLM Heckmann, Ma C, Ghisi M, Salmon JM, Matthews GM, de Valle E, Moujalled DM, Menon MB, Spall SK, Glaser SP, Richmond J, Lock RB, Condon SM, Gugasyan R, Gaestel M, Guthridge M, Johnstone RW, Munoz L, Wei A, Ekert PG, Vaux DL, Wong WW, Silke J (2016) Targeting p38 or MK2 enhances the anti-leukemic activity of smac-mimetics. Cancer Cell 29:145\u2013158", "journal-title": "Cancer Cell"}, {"key": "1107_CR46", "doi-asserted-by": "publisher", "first-page": "1205", "DOI": "10.1016/j.bbrc.2005.03.101", "volume": "330", "author": "HW Lee", "year": "2005", "unstructured": "Lee HW, Lee SH, Lee HW, Ryu YW, Kwon MH, Kim YS (2005) Homomeric and heteromeric interactions of the extracellular domains of death receptors and death decoy receptors. Biochem Biophys Res Commun 330:1205\u20131212", "journal-title": "Biochem Biophys Res Commun"}, {"key": "1107_CR47", "doi-asserted-by": "publisher", "first-page": "321", "DOI": "10.1126/science.284.5412.321", "volume": "284", "author": "Q Li", "year": "1999", "unstructured": "Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM (1999) Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284:321\u2013325", "journal-title": "Science"}, {"key": "1107_CR48", "doi-asserted-by": "publisher", "first-page": "1459", "DOI": "10.1038/cdd.2017.78", "volume": "24", "author": "Y Liu", "year": "2017", "unstructured": "Liu Y, Fan C, Zhang Y, Yu X, Wu X, Zhang X, Zhao Q, Zhang H, Xie Q, Li M, Li X, Ding Q, Ying H, Li D, Zhang H (2017) RIP1 kinase activity-dependent roles in embryonic development of Fadd-deficient mice. Cell Death Differ 24:1459\u20131469", "journal-title": "Cell Death Differ"}, {"key": "1107_CR49", "doi-asserted-by": "publisher", "first-page": "1248", "DOI": "10.1038/ncb3614", "volume": "19", "author": "MB Menon", "year": "2017", "unstructured": "Menon MB, Gropengie\u00dfer J, Fischer J, Novikova L, Deuretzbacher A, Lafera J, Schimmeck H, Czymmeck N, Ronkina N, Kotlyarov A, Aepfelbacher M, Gaestel M, Ruckdeschel K (2017) p38MAPK/MK2 dependent phosphorylation controls cytotoxic RIPK1 signaling in inflammation and infection. Nat Cell Biol 19:1248\u20131259", "journal-title": "Nat Cell Biol"}, {"key": "1107_CR50", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1016/S0092-8674(03)00521-X", "volume": "114", "author": "O Micheau", "year": "2003", "unstructured": "Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181\u2013190", "journal-title": "Cell"}, {"key": "1107_CR51", "doi-asserted-by": "publisher", "first-page": "1850", "DOI": "10.1016/j.celrep.2015.02.052", "volume": "10", "author": "M Najjar", "year": "2015", "unstructured": "Najjar M, Suebsuwong C, Ray SS, Thapa RJ, Maki JL, Nogusa S, Shah S, Saleh D, Gough PJ, Bertin J, Yuan J, Balachandran S, Cuny GD, Degterev A (2015) Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1. Cell Rep 10:1850\u20131860", "journal-title": "Cell Rep"}, {"key": "1107_CR52", "doi-asserted-by": "publisher", "first-page": "199", "DOI": "10.1038/nature11700", "volume": "492", "author": "N Narayan", "year": "2012", "unstructured": "Narayan N, Lee IH, Borenstein R, Sun J, Wong R, Tong G, Fergusson MM, Liu J, Rovira II, Cheng HL, Wang G, Gucek M, Lombard D, Alt FW, Sack MN, Murphy E, Cao L, Finkel T (2012) The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Nature 492:199\u2013204", "journal-title": "Nature"}, {"key": "1107_CR53", "doi-asserted-by": "publisher", "first-page": "418", "DOI": "10.1016/j.cub.2007.01.027", "volume": "17", "author": "MA O\u2019Donnell", "year": "2007", "unstructured": "O\u2019Donnell MA, Legarda-Addison D, Skountzos P, Yeh WC, Ting AT (2007) Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling. Curr Biol 17:418\u2013424", "journal-title": "Curr Biol"}, {"key": "1107_CR54", "doi-asserted-by": "publisher", "first-page": "1324", "DOI": "10.1016/j.yexcr.2012.01.019", "volume": "318", "author": "S Ozt\u00fcrk", "year": "2012", "unstructured": "Ozt\u00fcrk S, Schleich K, Lavrik IN (2012) Cellular FLICE-like inhibitory proteins (c-FLIPs): fine-tuners of life and death decisions. Exp Cell Res 318:1324\u20131331", "journal-title": "Exp Cell Res"}, {"key": "1107_CR55", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1016/j.celrep.2014.08.066", "volume": "9", "author": "N Peltzer", "year": "2014", "unstructured": "Peltzer N, Rieser E, Taraborrelli L, Draber P, Darding M, Pernaute B, Shimizu Y, Sarr A, Draberova H, Montinaro A, Martinez-Barbera JP, Silke J, Rodriguez TA, Walczak H (2014) HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell Rep 9:153\u2013165", "journal-title": "Cell Rep"}, {"key": "1107_CR56", "first-page": "123", "volume": "1805", "author": "B Pennarun", "year": "2010", "unstructured": "Pennarun B, Meijer A, de Vries EG, Kleibeuker JH, Kruyt F, de Jong S (2010) Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer. Biochim Biophys Acta 1805:123\u2013140", "journal-title": "Biochim Biophys Acta"}, {"key": "1107_CR57", "doi-asserted-by": "publisher", "first-page": "529", "DOI": "10.1016/j.cell.2004.10.017", "volume": "119", "author": "CG Pham", "year": "2004", "unstructured": "Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, Jayawardena S, De Smaele E, Cong R, Beaumont C, Torti FM, Torti SV, Franzoso G (2004) Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119:529\u2013542", "journal-title": "Cell"}, {"key": "1107_CR58", "doi-asserted-by": "publisher", "first-page": "5629", "DOI": "10.1038/onc.2016.99", "volume": "35", "author": "IR Powley", "year": "2016", "unstructured": "Powley IR, Hughes MA, Cain K, MacFarlane M (2016) Caspase-8 tyrosine-380 phosphorylation inhibits CD95 DISC function by preventing procaspase-8 maturation and cycling within the complex. Oncogene 35:5629\u20135640", "journal-title": "Oncogene"}, {"key": "1107_CR59", "doi-asserted-by": "publisher", "first-page": "94", "DOI": "10.1016/j.tibs.2012.11.007", "volume": "38", "author": "E Rieser", "year": "2013", "unstructured": "Rieser E, Cordier SM, Walczak H (2013) Linear ubiquitination: a newly discovered regulator of cell signalling. Trends Biochem Sci 38:94\u2013102", "journal-title": "Trends Biochem Sci"}, {"key": "1107_CR60", "doi-asserted-by": "publisher", "first-page": "36530", "DOI": "10.1074/jbc.M104837200", "volume": "276", "author": "K Tada", "year": "2001", "unstructured": "Tada K, Okazaki T, Sakon S, Kobarai T, Kurosawa K, Yamaoka S, Hashimoto H, Mak TW, Yagita H, Okumura K, Yeh WC, Nakano H (2001) Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. J Biol Chem 276:36530\u201336534", "journal-title": "J Biol Chem"}, {"key": "1107_CR61", "doi-asserted-by": "publisher", "first-page": "e437", "DOI": "10.1038/cddis.2012.176", "volume": "29", "author": "N Takahashi", "year": "2012", "unstructured": "Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway JB, Goossens V, Roelandt R, Van Hauwermeiren F, Libert C, Declercq W, Callewaert N, Prendergast GC, Degterev A, Yuan J, Vandenabeele P (2012) Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis 29:e437", "journal-title": "Cell Death Dis"}, {"key": "1107_CR62", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1038/nature13706", "volume": "513", "author": "N Takahashi", "year": "2014", "unstructured": "Takahashi N, Vereecke L, Bertrand MJ, Duprez L, Berger SB, Divert T, Gon\u00e7alves A, Sze M, Gilbert B, Kourula S, Goossens V, Lefebvre S, G\u00fcnther C, Becker C, Bertin J, Gough PJ, Declercq W, van Loo G, Vandenabeele P (2014) RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 513:95\u201399", "journal-title": "Nature"}, {"key": "1107_CR63", "doi-asserted-by": "publisher", "first-page": "517", "DOI": "10.1172/JCI95410", "volume": "128", "author": "H Tamiya", "year": "2018", "unstructured": "Tamiya H, Kim H, Klymenko O, Kim H, Feng Y, Zhang T, Han JY, Murao A, Snipas SJ, Jilaveanu L, Brown K, Kluger H, Zhang H, Iwai K, Ronai ZA (2018) SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth. J Clin Invest 128:517\u2013530", "journal-title": "J Clin Invest"}, {"key": "1107_CR64", "doi-asserted-by": "publisher", "first-page": "313", "DOI": "10.1038/35104568", "volume": "414", "author": "G Tang", "year": "2001", "unstructured": "Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M, Lin A (2001) Inhibition of JNK activation through NF-kappaB target genes. Nature 414:313\u2013317", "journal-title": "Nature"}, {"key": "1107_CR65", "doi-asserted-by": "publisher", "first-page": "563", "DOI": "10.1016/j.micinf.2012.01.011", "volume": "14", "author": "F Tokunaga", "year": "2012", "unstructured": "Tokunaga F, Iwai K (2012) LUBAC, a novel ubiquitin ligase for linear ubiquitination, is crucial for inflammation and immune responses. Microbes Infect 14:563\u2013572", "journal-title": "Microbes Infect"}, {"key": "1107_CR66", "doi-asserted-by": "publisher", "first-page": "30321", "DOI": "10.3390/ijms161226232", "volume": "16", "author": "Y Tsuchiya", "year": "2015", "unstructured": "Tsuchiya Y, Nakabayashi O, Nakano H (2015) FLIP the switch: regulation of apoptosis and necroptosis by cFLIP. Int J Mol Sci 16:30321\u201330341", "journal-title": "Int J Mol Sci"}, {"key": "1107_CR67", "doi-asserted-by": "publisher", "first-page": "76", "DOI": "10.1111/imr.12541", "volume": "277", "author": "B Tummers", "year": "2017", "unstructured": "Tummers B, Green DR (2017) Caspase-8: regulating life and death. Immunol Rev 277:76\u201389", "journal-title": "Immunol Rev"}, {"key": "1107_CR68", "doi-asserted-by": "publisher", "first-page": "693", "DOI": "10.1146/annurev.immunol.021908.132641", "volume": "27", "author": "S Vallabhapurapu", "year": "2009", "unstructured": "Vallabhapurapu S, Karin M (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27:693\u2013733", "journal-title": "Annu Rev Immunol"}, {"key": "1107_CR69", "doi-asserted-by": "publisher", "first-page": "re4", "DOI": "10.1126/scisignal.3115re4", "volume": "3", "author": "P Vandenabeele", "year": "2010", "unstructured": "Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T (2010) The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal 3:re4", "journal-title": "Sci Signal"}, {"key": "1107_CR70", "doi-asserted-by": "publisher", "first-page": "e230", "DOI": "10.1038/cddis.2011.111", "volume": "17", "author": "N Vanlangenakker", "year": "2011", "unstructured": "Vanlangenakker N, Bertrand MJ, Bogaert P, Vandenabeele P, Vanden Berghe T (2011a) TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis 17:e230", "journal-title": "Cell Death Dis"}, {"key": "1107_CR71", "doi-asserted-by": "publisher", "first-page": "656", "DOI": "10.1038/cdd.2010.138", "volume": "18", "author": "N Vanlangenakker", "year": "2011", "unstructured": "Vanlangenakker N, Vanden Berghe T, Bogaert P, Laukens B, Zobel K, Deshayes K, Vucic D, Fulda S, Vandenabeele P, Bertrand MJ (2011b) cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ 18:656\u2013665", "journal-title": "Cell Death Differ"}, {"key": "1107_CR72", "doi-asserted-by": "publisher", "first-page": "1511", "DOI": "10.4161/cc.7.11.5959", "volume": "7", "author": "E Varfolomeev", "year": "2008", "unstructured": "Varfolomeev E, Vucic D (2008) (Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways. Cell Cycle 7:1511\u20131521", "journal-title": "Cell Cycle"}, {"key": "1107_CR73", "doi-asserted-by": "publisher", "first-page": "24295", "DOI": "10.1074/jbc.C800128200", "volume": "283", "author": "E Varfolomeev", "year": "2008", "unstructured": "Varfolomeev E, Goncharov T, Fedorova AV, Dynek JN, Zobel K, Deshayes K, Fairbrother WJ, Vucic D (2008) c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem 283:24295\u201324299", "journal-title": "J Biol Chem"}, {"key": "1107_CR74", "doi-asserted-by": "publisher", "first-page": "553", "DOI": "10.1016/j.immuni.2016.02.020", "volume": "44", "author": "K Vlantis", "year": "2016", "unstructured": "Vlantis K, Wullaert A, Polykratis A, Kondylis V, Dannappel M, Schwarzer R, Welz P, Corona T, Walczak H, Weih F, Klein U, Kelliher M, Pasparakis M (2016) NEMO prevents RIP kinase 1-mediated epithelial cell death and chronic intestinal inflammation by NF-\u03baB-dependent and -independent functions. Immunity 44:553\u2013567", "journal-title": "Immunity"}, {"key": "1107_CR75", "doi-asserted-by": "publisher", "first-page": "1070", "DOI": "10.1038/nm1627", "volume": "13", "author": "KW Wagner", "year": "2007", "unstructured": "Wagner KW, Punnoose EA, Januario T, Lawrence DA, Pitti RM, Lancaster K, Lee D, von Goetz M, Yee SF, Totpal K, Huw L, Katta V, Cavet G, Hymowitz SG, Amler L, Ashkenazi A (2007) Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat Med 13:1070\u20131077", "journal-title": "Nat Med"}, {"key": "1107_CR76", "doi-asserted-by": "publisher", "first-page": "346", "DOI": "10.1038/35085597", "volume": "412", "author": "C Wang", "year": "2001", "unstructured": "Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412:346\u2013351", "journal-title": "Nature"}, {"key": "1107_CR77", "doi-asserted-by": "publisher", "first-page": "693", "DOI": "10.1016/j.cell.2008.03.036", "volume": "133", "author": "L Wang", "year": "2008", "unstructured": "Wang L, Du F, Wang X (2008) TNF-\u03b1 induces two distinct caspase-8 activation pathways. Cell 133:693\u2013703", "journal-title": "Cell"}, {"key": "1107_CR78", "doi-asserted-by": "publisher", "first-page": "1631", "DOI": "10.1007/s00018-010-0289-7", "volume": "67", "author": "R Weinlich", "year": "2010", "unstructured": "Weinlich R, Brunner T, Amarante-Mendes GP (2010) Control of death receptor ligand activity by posttranslational modifications. Cell Mol Life Sci 67:1631\u20131642", "journal-title": "Cell Mol Life Sci"}, {"key": "1107_CR79", "doi-asserted-by": "publisher", "first-page": "1830", "DOI": "10.1038/cdd.2010.47", "volume": "17", "author": "M Won", "year": "2010", "unstructured": "Won M, Park KA, Byun HS, Sohn KC, Kim YR, Jeon J, Hong JH, Park J, Seok JH, Kim JM, Yoon WH, Jang IS, Shen HM, Liu ZG, Hur GM (2010) Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation. Cell Death Differ 17:1830\u20131841", "journal-title": "Cell Death Differ"}, {"key": "1107_CR80", "doi-asserted-by": "publisher", "first-page": "1075", "DOI": "10.1007/s12272-016-0772-2", "volume": "39", "author": "M Won", "year": "2016", "unstructured": "Won M, Byun HS, Park KA, Hur GM (2016) Post-translational control of NF-\u03baB signaling by ubiquitination. Arch Pharm Res 39:1075\u20131084", "journal-title": "Arch Pharm Res"}, {"key": "1107_CR81", "doi-asserted-by": "publisher", "first-page": "10558", "DOI": "10.1021/bi901462e", "volume": "48", "author": "Q Yin", "year": "2009", "unstructured": "Yin Q, Lamothe B, Darnay BG, Wu H (2009) Structural basis for the lack of E2 interaction in the RING domain of TRAF2. Biochemistry 48:10558\u201319567", "journal-title": "Biochemistry"}, {"key": "1107_CR82", "doi-asserted-by": "publisher", "first-page": "427", "DOI": "10.1093/rheumatology/kes292", "volume": "52", "author": "HK Yoon", "year": "2013", "unstructured": "Yoon HK, Byun HS, Lee H, Jeon J, Lee Y, Li Y, Jin EH, Kim J, Hong JH, Kim JH, Seok JH, Kang SW, Lee WH, Hur GM (2013) Intron-derived aberrant splicing of A20 transcript in rheumatoid arthritis. Rheumatology (Oxford) 52:427\u2013437", "journal-title": "Rheumatology (Oxford)"}, {"key": "1107_CR83", "doi-asserted-by": "publisher", "first-page": "528", "DOI": "10.1016/j.jmb.2010.01.008", "volume": "396", "author": "L Zhang", "year": "2010", "unstructured": "Zhang L, Blackwell K, Shi Z, Habelhah H (2010) The RING domain of TRAF2 plays an essential role in the inhibition of TNF\u03b1-induced cell death but not in the activation of NF-\u03baB. J Mol Biol 396:528\u2013539", "journal-title": "J Mol Biol"}, {"key": "1107_CR84", "doi-asserted-by": "publisher", "first-page": "2062", "DOI": "10.1038/ncomms3062", "volume": "4", "author": "T Zhang", "year": "2013", "unstructured": "Zhang T, Park KA, Li Y, Byun HS, Jeon J, Lee Y, Hong JH, Kim JM, Huang SM, Choi SW, Kim SH, Sohn KC, Ro H, Lee JH, Lu T, Stark GR, Shen HM, Liu ZG, Park J, Hur GM (2013) PHF20 regulates NF-\u03baB signalling by disrupting recruitment of PP2A to p65. Nat Commun 4:2062", "journal-title": "Nat Commun"}, {"key": "1107_CR85", "doi-asserted-by": "publisher", "first-page": "22076", "DOI": "10.1074/jbc.M115.658096", "volume": "290", "author": "Y Zhao", "year": "2015", "unstructured": "Zhao Y, Ma CA, Wu L, Iwai K, Ashwell JD, Oltz EM, Ballard DW, Jain A (2015) CYLD and the NEMO zinc finger regulate tumor necrosis factor signaling and early embryogenesis. J Biol Chem 290:22076\u201322084", "journal-title": "J Biol Chem"}, {"key": "1107_CR86", "doi-asserted-by": "publisher", "first-page": "798", "DOI": "10.1016/j.celrep.2017.04.011", "volume": "19", "author": "Q Zhao", "year": "2017", "unstructured": "Zhao Q, Yu X, Zhang H, Liu Y, Zhang X, Wu X, Xie Q, Li M, Ying H, Zhang H (2017) RIPK3 mediates necroptosis during embryonic development and postnatal inflammation in FADD-deficient mice. Cell Rep 19:798\u2013808", "journal-title": "Cell Rep"}], "container-title": ["Archives of Pharmacal Research"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s12272-018-01107-8/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s12272-018-01107-8.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s12272-018-01107-8.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 6]], "date-time": "2019-09-06T17:01:26Z", "timestamp": 1567789286000}, "score": 19.64965, "issued": {"date-parts": [[2019, 1]]}, "references-count": 90, "journal-issue": {"published-print": {"date-parts": [[2019, 1]]}, "issue": "1"}, "alternative-id": ["1107"], "URL": "http://dx.doi.org/10.1007/s12272-018-01107-8", "relation": {"cites": []}, "ISSN": ["0253-6269", "1976-3786"], "issn-type": [{"value": "0253-6269", "type": "print"}, {"value": "1976-3786", "type": "electronic"}], "subject": ["Organic Chemistry", "Molecular Medicine", "Drug Discovery"], "assertion": [{"value": "17 October 2018", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "27 December 2018", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "4 January 2019", "order": 3, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Compliance with ethical standards"}}, {"value": "The authors declared no conflict of interest.", "order": 2, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Conflict of interest"}}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T11:54:55Z", "timestamp": 1574510095618}, "reference-count": 0, "publisher": "Informa UK Limited", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/3.0/", "start": {"date-parts": [[2012, 10, 1]], "date-time": "2012-10-01T00:00:00Z", "timestamp": 1349049600000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JEP"], "DOI": "10.2147/jep.s27078", "type": "journal-article", "created": {"date-parts": [[2012, 10, 12]], "date-time": "2012-10-12T01:06:32Z", "timestamp": 1350003992000}, "page": "141", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The therapeutic potential of ROR&gamma; modulators in the treatment of human disease"], "prefix": "10.2147", "author": [{"given": "Patrick", "family": "Griffin", "sequence": "first", "affiliation": []}, {"given": "Mi Ra", "family": "Chang", "sequence": "additional", "affiliation": []}, {"family": "Goswami", "sequence": "additional", "affiliation": []}, {"family": "Mercer", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2012, 10]]}, "container-title": ["Journal of Experimental Pharmacology"], "language": "en", "link": [{"URL": "https://www.dovepress.com/getfile.php?fileID=14226", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 10, 30]], "date-time": "2016-10-30T22:28:09Z", "timestamp": 1477866489000}, "score": 19.18705, "issued": {"date-parts": [[2012, 10]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2147/jep.s27078", "ISSN": ["1179-1454"], "issn-type": [{"value": "1179-1454", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T08:26:57Z", "timestamp": 1574497617919}, "reference-count": 0, "publisher": "F1000 Research Ltd", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011, 10, 20]]}, "DOI": "10.3410/f.13067956.14726319", "type": "dataset", "created": {"date-parts": [[2012, 8, 20]], "date-time": "2012-08-20T11:55:47Z", "timestamp": 1345463747000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Faculty of 1000 evaluation for Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets."], "prefix": "10.3410", "author": [{"given": "Patrick", "family": "Duffy", "sequence": "first", "affiliation": []}], "member": "2560", "content-created": {"date-parts": [[2011, 10, 20]]}, "container-title": ["F1000 - Post-publication peer review of the biomedical literature"], "deposited": {"date-parts": [[2015, 1, 26]], "date-time": "2015-01-26T10:55:13Z", "timestamp": 1422269713000}, "score": 19.044744, "issued": {"date-parts": [[2011, 10, 20]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3410/f.13067956.14726319"}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T19:35:36Z", "timestamp": 1575228936521}, "reference-count": 0, "publisher": "Oxford University Press", "isbn-type": [{"value": "9780199592753", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 4]]}, "DOI": "10.1093/med/9780199592753.003.0015", "type": "book-chapter", "created": {"date-parts": [[2013, 5, 30]], "date-time": "2013-05-30T09:53:30Z", "timestamp": 1369907610000}, "page": "269-287", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The body, trauma, and narrative approaches to healing"], "prefix": "10.1093", "author": [{"given": "Maureen", "family": "Duffy", "sequence": "first", "affiliation": []}], "member": "286", "container-title": ["Discursive Perspectives in Therapeutic Practice"], "deposited": {"date-parts": [[2017, 11, 7]], "date-time": "2017-11-07T15:04:06Z", "timestamp": 1510067046000}, "score": 18.932255, "issued": {"date-parts": [[2012, 4]]}, "ISBN": ["9780199592753"], "references-count": 0, "URL": "http://dx.doi.org/10.1093/med/9780199592753.003.0015"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T20:52:13Z", "timestamp": 1574801533176}, "reference-count": 0, "publisher": "Royal College of Physicians of Edinburgh", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J R Coll Physicians Edinb"], "published-print": {"date-parts": [[2016]]}, "DOI": "10.4997/jrcpe.2016.403", "type": "journal-article", "created": {"date-parts": [[2017, 6, 28]], "date-time": "2017-06-28T13:55:46Z", "timestamp": 1498658146000}, "page": "228-233", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Yoshinori Ohsumi\u2019s Nobel Prize for mechanisms of autophagy: from basic yeast biology to therapeutic potential"], "prefix": "10.4997", "volume": "46", "author": [{"given": "RA", "family": "Frake", "sequence": "first", "affiliation": []}, {"given": "DC", "family": "Rubinsztein", "sequence": "additional", "affiliation": []}], "member": "2903", "published-online": {"date-parts": [[2016]]}, "container-title": ["Journal of the Royal College of Physicians of Edinburgh"], "link": [{"URL": "http://www.rcpe.ac.uk/sites/default/files/jrcpe_46_4_rubinsztein.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 28]], "date-time": "2017-06-28T13:55:48Z", "timestamp": 1498658148000}, "score": 18.787872, "issued": {"date-parts": [[2016]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016]]}, "published-print": {"date-parts": [[2016]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.4997/jrcpe.2016.403", "ISSN": ["1478-2715", "2042-8189"], "issn-type": [{"value": "1478-2715", "type": "print"}, {"value": "2042-8189", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T18:07:36Z", "timestamp": 1574532456335}, "reference-count": 0, "publisher": "Japanese Society of Internal Medicine", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Jpn. Soc. Intern. Med"], "published-print": {"date-parts": [[1998]]}, "DOI": "10.2169/naika.87.1568", "type": "journal-article", "created": {"date-parts": [[2011, 8, 4]], "date-time": "2011-08-04T11:02:34Z", "timestamp": 1312455754000}, "page": "1568-1576", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Fc Receptor Redux Role of immunoglobulin receptor (FcR) in glomerulonephritis."], "prefix": "10.2169", "volume": "87", "author": [{"given": "CHISEI", "family": "RA", "sequence": "first", "affiliation": []}], "member": "962", "container-title": ["Nihon Naika Gakkai Zasshi"], "original-title": ["\uff26\uff43\u3000\uff52\uff45\uff43\uff45\uff50\uff54\uff4f\uff52\u3000\uff32\uff45\uff44\uff55\uff58\u3000\u7cf8\u7403\u4f53\u814e\u708e\u306b\u304a\u3051\u308b\u514d\u75ab\u30b0\u30ed\u30d6\u30ea\u30f3\u30ec\u30bb\u30d7\u30bf\u30fc\uff08\uff26\uff43\uff32\uff09\u306e\u5f79\u5272"], "language": "ja", "deposited": {"date-parts": [[2011, 8, 4]], "date-time": "2011-08-04T11:05:03Z", "timestamp": 1312455903000}, "score": 18.772924, "issued": {"date-parts": [[1998]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1998]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.2169/naika.87.1568", "ISSN": ["0021-5384", "1883-2083"], "issn-type": [{"value": "0021-5384", "type": "print"}, {"value": "1883-2083", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T19:35:35Z", "timestamp": 1575228935797}, "reference-count": 0, "publisher": "Oxford University Press", "isbn-type": [{"value": "9780199592753", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 4]]}, "DOI": "10.1093/med/9780199592753.003.0008", "type": "book-chapter", "created": {"date-parts": [[2013, 5, 30]], "date-time": "2013-05-30T09:53:30Z", "timestamp": 1369907610000}, "page": "143-162", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Solution-focused brief therapy: listening in the present with an ear toward the future"], "prefix": "10.1093", "author": [{"given": "Maureen", "family": "Duffy", "sequence": "first", "affiliation": []}], "member": "286", "container-title": ["Discursive Perspectives in Therapeutic Practice"], "deposited": {"date-parts": [[2017, 11, 7]], "date-time": "2017-11-07T15:04:03Z", "timestamp": 1510067043000}, "score": 18.195774, "issued": {"date-parts": [[2012, 4]]}, "ISBN": ["9780199592753"], "references-count": 0, "URL": "http://dx.doi.org/10.1093/med/9780199592753.003.0008"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T23:23:57Z", "timestamp": 1574465037440}, "reference-count": 0, "publisher": "Informa UK Limited", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["DMSOTT"], "DOI": "10.2147/dmsott.s3987", "type": "journal-article", "created": {"date-parts": [[2010, 9, 16]], "date-time": "2010-09-16T02:20:37Z", "timestamp": 1284603637000}, "page": "1", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design"], "prefix": "10.2147", "author": [{"given": "Helen", "family": "Duffy", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 1]]}, "container-title": ["Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"], "language": "en", "deposited": {"date-parts": [[2010, 9, 16]], "date-time": "2010-09-16T02:20:41Z", "timestamp": 1284603641000}, "score": 17.982485, "issued": {"date-parts": [[2009, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2147/dmsott.s3987", "ISSN": ["1178-7007"], "issn-type": [{"value": "1178-7007", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T20:18:01Z", "timestamp": 1574713081525}, "reference-count": 0, "publisher": "Informa UK Limited", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/3.0/", "start": {"date-parts": [[2009, 1, 1]], "date-time": "2009-01-01T00:00:00Z", "timestamp": 1230768000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["DMSO"], "DOI": "10.2147/dmso.s3987", "type": "journal-article", "created": {"date-parts": [[2016, 10, 31]], "date-time": "2016-10-31T01:29:26Z", "timestamp": 1477877366000}, "page": "1-10", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design"], "prefix": "10.2147", "volume": "Volume 2", "author": [{"given": "Helen", "family": "Duffy", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 1]]}, "container-title": ["Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"], "language": "en", "link": [{"URL": "https://www.dovepress.com/getfile.php?fileID=4250", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://www.dovepress.com/getfile.php?fileID=4250", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 10, 31]], "date-time": "2016-10-31T01:29:27Z", "timestamp": 1477877367000}, "score": 17.982485, "issued": {"date-parts": [[2009, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2147/dmso.s3987", "ISSN": ["1178-7007"], "issn-type": [{"value": "1178-7007", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T04:51:31Z", "timestamp": 1575175891015}, "reference-count": 53, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1992, 1, 1]], "date-time": "1992-01-01T00:00:00Z", "timestamp": 694224000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biotherapy"], "published-print": {"date-parts": [[1992, 1]]}, "DOI": "10.1007/bf02171709", "type": "journal-article", "created": {"date-parts": [[2005, 9, 17]], "date-time": "2005-09-17T05:25:04Z", "timestamp": 1126934704000}, "page": "45-52", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Inhibiting tissue invasion and metastasis as targets for cancer therapy"], "prefix": "10.1007", "volume": "4", "author": [{"given": "M. J.", "family": "Duffy", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "BF02171709_CR1", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S0065-230X(08)60942-2", "volume": "43", "author": "V Schirrmacher", "year": "1985", "unstructured": "Schirrmacher V. Cancer metastasis: experimental approaches, theoretical concepts and impact for treatment strategies. Adv Cancer Res 1985; 43: 1\u201373.", "journal-title": "Adv Cancer Res"}, {"key": "BF02171709_CR2", "first-page": "227", "volume": "780", "author": "D Tarin", "year": "1985", "unstructured": "Tarin D. Clinical and experimental studies on the biology of metastasis. Biochim Biophys Acta 1985; 780: 227\u201335.", "journal-title": "Biochim Biophys Acta"}, {"key": "BF02171709_CR3", "first-page": "191", "volume": "907", "author": "K Tryggvason", "year": "1987", "unstructured": "Tryggvason K, Hayhtya M, Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 1987; 907: 191\u2013217.", "journal-title": "Biochim Biophys Acta"}, {"key": "BF02171709_CR4", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.1111/j.1432-1033.1989.tb14673.x", "volume": "180", "author": "R Timpl", "year": "1989", "unstructured": "Timpl R. Structure and biological activity of basement membrane proteins. Eur J Biochem 1989; 180: 487\u2013502.", "journal-title": "Eur J Biochem"}, {"key": "BF02171709_CR5", "doi-asserted-by": "crossref", "first-page": "1123", "DOI": "10.1001/jama.1990.03440080101032", "volume": "263", "author": "L Liotta", "year": "1990", "unstructured": "Liotta L, Kohn E. Cancer invasion and metastasis. JAMA 1990; 263: 1123\u20136.", "journal-title": "JAMA"}, {"key": "BF02171709_CR6", "doi-asserted-by": "crossref", "first-page": "491", "DOI": "10.1126/science.2821619", "volume": "238", "author": "E Ruoslahti", "year": "1987", "unstructured": "Ruoslahti E, Pierschbacher M. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491\u20137.", "journal-title": "Science"}, {"key": "BF02171709_CR7", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1016/0304-4157(90)90004-V", "volume": "1031", "author": "SK Akiyama", "year": "1990", "unstructured": "Akiyama SK, Nagata K, Yamada K. Cell surface receptors for extracellular matrix components. Biochim Biophys Acta 1990; 1031: 91\u2013110.", "journal-title": "Biochim Biophys Acta"}, {"key": "BF02171709_CR8", "first-page": "5691", "volume": "47", "author": "UM Wewer", "year": "1987", "unstructured": "Wewer UM, Tarabolletti G, Sobel ME, Albrechtsen R, Liotta L. Laminin receptor: role in tumor cell migration. Cancer Res 1987; 47: 5691\u20138.", "journal-title": "Cancer Res"}, {"key": "BF02171709_CR9", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1038/309030a0", "volume": "309", "author": "M Pierschbacher", "year": "1984", "unstructured": "Pierschbacher M, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984; 309: 30\u20133.", "journal-title": "Nature"}, {"key": "BF02171709_CR10", "doi-asserted-by": "crossref", "first-page": "585", "DOI": "10.1083/jcb.104.3.585", "volume": "104", "author": "S Dedhar", "year": "1987", "unstructured": "Dedhar S, Ruoslahti E, Perschbacher M. A cell surface receptor complex for collagen type 1 recognizes the Arg-Gly-Asp sequence. J Cell Biol 1987; 104: 585\u201393.", "journal-title": "J Cell Biol"}, {"key": "BF02171709_CR11", "doi-asserted-by": "crossref", "first-page": "1132", "DOI": "10.1126/science.2961059", "volume": "238", "author": "Y Iwamoto", "year": "1987", "unstructured": "Iwamoto Y, Robey FA, Graf J et al. YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 1987; 238: 1132\u20134.", "journal-title": "Science"}, {"key": "BF02171709_CR12", "doi-asserted-by": "crossref", "first-page": "583", "DOI": "10.1016/0277-5379(87)90326-9", "volume": "23", "author": "MJ Duffy", "year": "1987", "unstructured": "Duffy MJ. Do proteases play a role in cancer invasion and metastasis. Eur J Cancer Clin Oncol 1987; 23: 583\u20139.", "journal-title": "Eur J Cancer Clin Oncol"}, {"key": "BF02171709_CR13", "first-page": "681", "volume": "1", "author": "MJ Duffy", "year": "1990", "unstructured": "Duffy MJ. Plasminogen activators and cancer. Blood Coag Fibrinol 1990; 1: 681\u20137.", "journal-title": "Blood Coag Fibrinol"}, {"key": "BF02171709_CR14", "first-page": "177", "volume": "695", "author": "DE Mullins", "year": "1983", "unstructured": "Mullins DE, Rohrlich ST. The role of proteinases in cellular invasiveness. Biochim Biophys Acta 1983; 695: 177\u2013214.", "journal-title": "Biochim Biophys Acta"}, {"key": "BF02171709_CR15", "first-page": "6600", "volume": "261", "author": "GI Goldberg", "year": "1986", "unstructured": "Goldberg GI, Wilhelm SM, Kronberger A et al. Human fibroblast collagenase: complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 1986; 261: 6600\u20135.", "journal-title": "J Biol Chem"}, {"key": "BF02171709_CR16", "first-page": "5431", "volume": "50", "author": "M Smyth Templeton", "year": "1990", "unstructured": "Smyth Templeton M, Brown PD, Levy AT et al. Cloning and characterization of human tumor cell interstitial collagenase. Cancer Res 1990; 50: 5431\u20137.", "journal-title": "Cancer Res"}, {"key": "BF02171709_CR17", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1021/bi00504a017", "volume": "20", "author": "L Liotta", "year": "1981", "unstructured": "Liotta L Tryggvason K Garbisa S et al. Partial purification and characterization of a neutral protease which cleaves type IV collagen. Biochemistry 1981; 20: 100\u20134.", "journal-title": "Biochemistry"}, {"key": "BF02171709_CR18", "first-page": "17213", "volume": "264", "author": "SM Wilhelm", "year": "1989", "unstructured": "Wilhelm SM, Collier IE, Marmer BL et al. SV40 transformed human lung fibroblasts secrete a 92 kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264: 17213\u201321.", "journal-title": "J Biol Chem"}, {"key": "BF02171709_CR19", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1016/0014-5793(90)80967-N", "volume": "268", "author": "Y Kato", "year": "1990", "unstructured": "Kato Y, Ogawa K, Yamamoto S et al. A novel TIMP insensitive type IV collagen-degrading metal loproteinase from murine metastatic sarcoma cells. FEBS 1990; 268: 39\u201342.", "journal-title": "FEBS"}, {"key": "BF02171709_CR20", "first-page": "391", "volume": "9", "author": "R Khokha", "year": "1989", "unstructured": "Khokha R, Denhardt DT. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: a review of their role in tumorigenesis and tissue invasion. Inv Met 1989; 9: 391\u2013405.", "journal-title": "Inv Met"}, {"key": "BF02171709_CR21", "first-page": "13933", "volume": "265", "author": "WG Stetler-Stevenson", "year": "1990", "unstructured": "Stetler-Stevenson WG, Brown PD, Onisto M et al. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990; 265: 13933\u20138.", "journal-title": "J Biol Chem"}, {"key": "BF02171709_CR22", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/S0065-230X(08)60028-7", "volume": "44", "author": "K Dano", "year": "1987", "unstructured": "Dano K, Andreason PA, Grondahl-Hansen P et al. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1987; 44: 139\u2013266.", "journal-title": "Adv Cancer Res"}, {"key": "BF02171709_CR23", "doi-asserted-by": "crossref", "first-page": "577", "DOI": "10.1016/0277-5379(84)90001-4", "volume": "20", "author": "MJ Duffy", "year": "1984", "unstructured": "Duffy MJ, O'Grady P. Plasminogen and cancer. Eur J Cancer Clin Oncol 1984; 20: 577\u201382.", "journal-title": "Eur J Cancer Clin Oncol"}, {"key": "BF02171709_CR24", "doi-asserted-by": "crossref", "first-page": "4939", "DOI": "10.1073/pnas.82.15.4939", "volume": "82", "author": "MP Stopelli", "year": "1985", "unstructured": "Stopelli MP, Corti A, Soffientini A et al. Differentiation enhanced binding of the amino terminal fragment of human urokinase plasminogen activator to a specific receptor on 11937 monocytes. Proc Natl Acad Sci USA 1985; 82: 4939\u201343.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF02171709_CR25", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.1083/jcb.100.1.86", "volume": "100", "author": "J-D Vassali", "year": "1985", "unstructured": "Vassali J-D, Baccino D, Belin D. A cellular binding site for the Mr 55,000 form of the human plasminogen activator. J Cell Biol 1985; 100: 86\u201392.", "journal-title": "J Cell Biol"}, {"key": "BF02171709_CR26", "doi-asserted-by": "crossref", "first-page": "2437", "DOI": "10.1083/jcb.107.6.2437", "volume": "107", "author": "L Ossowski", "year": "1988", "unstructured": "Ossowski L.In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase. J Cell Biol 1988; 107: 2437\u201345.", "journal-title": "J Cell Biol"}, {"key": "BF02171709_CR27", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/0303-7207(90)90164-4", "volume": "68", "author": "PA Andreasen", "year": "1990", "unstructured": "Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN. Plasminogen activator inhibitors: hormonally regulated serpins. Moll Cell Endocrinol 1990; 68: 1\u201319.", "journal-title": "Moll Cell Endocrinol"}, {"key": "BF02171709_CR28", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1016/0268-9499(87)90037-3", "volume": "1", "author": "B Astedt", "year": "1987", "unstructured": "Astedt B, Lecander I, My T. The placental type Plasminogen activator inhibitor, PAI 2. Fibrinolysis 1987; 1: 203\u20138.", "journal-title": "Fibrinolysis"}, {"key": "BF02171709_CR29", "first-page": "35", "volume": "823", "author": "O Saksela", "year": "1985", "unstructured": "Saksela O. Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta 1985; 823: 35\u201365.", "journal-title": "Biochim Biophys Acta"}, {"key": "BF02171709_CR30", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1007/BF00048388", "volume": "3", "author": "BF Sloane", "year": "1984", "unstructured": "Sloane BF, Honn KV. Cysteine proteinases and metastasis. Cancer Met Rev 1984; 3: 249\u201363.", "journal-title": "Cancer Met Rev"}, {"key": "BF02171709_CR31", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1016/0005-2744(80)90174-6", "volume": "614", "author": "JS Mort", "year": "1980", "unstructured": "Mort JS, Recklies AD, Poole AR. Characterization of a thiol proteinase secreted by malignant human breast tumors. Biochem Biophys Acta 1980; 614: 134\u201343.", "journal-title": "Biochem Biophys Acta"}, {"key": "BF02171709_CR32", "first-page": "8536", "volume": "256", "author": "RJ Pietras", "year": "1981", "unstructured": "Pietras RJ, Roberts JA. Cathepsin B-like enzymes, subcellular distribution and properties in neoplastic and control cells from human ectocervix. J Biol Chem 1981;256: 8536\u201344.", "journal-title": "J Biol Chem"}, {"key": "BF02171709_CR33", "doi-asserted-by": "crossref", "first-page": "2483", "DOI": "10.1073/pnas.83.8.2483", "volume": "83", "author": "BF Sloane", "year": "1986", "unstructured": "Sloane BF, Rozhin J, Johnson K et al. Cathepsin B: association with plasma membrane in metastatic tumors. Proc Natl Acad Sci USA 1986; 83: 2483\u20137.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF02171709_CR34", "first-page": "1416", "volume": "48", "author": "Z Keren", "year": "1988", "unstructured": "Keren Z, LeGrue SJ. Identification of cell surface cathepsin B-like activity on murine melanomas and fibrosarcomas: modulation by butanol extraction. Cancer Res 1988; 48: 1416\u201321.", "journal-title": "Cancer Res"}, {"issue": "Suppl", "key": "BF02171709_CR35", "first-page": "199", "volume": "371", "author": "TT Lah", "year": "1990", "unstructured": "Lah TT, Kokalj-Kunovar M, Turk V. Cysteine proteinase inhibitors in human cancerous tissues and fluids. Biol Chem Hoppe-Seyler 1990; 371 (Suppl): 199\u2013203.", "journal-title": "Biol Chem Hoppe-Seyler"}, {"key": "BF02171709_CR36", "first-page": "605", "volume": "322", "author": "BR Zetter", "year": "1989", "unstructured": "Zetter BR. The cellular basis of site specific tumor metastasis. N Eng J Med 1989; 322: 605\u201312.", "journal-title": "N Eng J Med"}, {"key": "BF02171709_CR37", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1126/science.3726541", "volume": "233", "author": "MJ Humphries", "year": "1986", "unstructured": "Humphries MJ, Olden K, Yamada KM. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986; 233: 467\u201370.", "journal-title": "Science"}, {"key": "BF02171709_CR38", "doi-asserted-by": "crossref", "first-page": "194", "DOI": "10.1038/bjc.1989.40", "volume": "59", "author": "I Saiki", "year": "1989", "unstructured": "Saiki I, Murata J, Iida J et al. The inhibition of murine lung metastasis by synthetic polypeptides [poly(Arg-Gly-Asp) and poly(Tyr-lie-Gly-Ser-Arg)] with a core sequence of cell adhesion molecules. Br J Cancer 1989; 59: 194\u20137.", "journal-title": "Br J Cancer"}, {"key": "BF02171709_CR39", "first-page": "3815", "volume": "49", "author": "I Saiki", "year": "1989", "unstructured": "Saiki I, Joyi I, Murata J et al. Inhibition of the metastasis of murine malignant melanoma cells by synthetic polymeric peptides containing core sequences of cell adhesive molecules. Cancer Res 1989; 49: 3815\u201322.", "journal-title": "Cancer Res"}, {"key": "BF02171709_CR40", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1016/S0305-7372(77)80025-X", "volume": "4", "author": "HI Peterson", "year": "1977", "unstructured": "Peterson HI. Fibrinolysis and antifibrinolytic drugs in the growth and spread of tumors. Cancer Treat Rev 1977; 4: 213\u20137.", "journal-title": "Cancer Treat Rev"}, {"key": "BF02171709_CR41", "first-page": "149", "volume": "1", "author": "N Tanaka", "year": "1981", "unstructured": "Tanaka N, Ogawa H, Tanaka K, Kinjo M, Kohga S. Effects of tranexamic acid and urokinase on hematogenous metastases of Lewis lung carcinoma in mice. Invasion Metastasis 1981; 1: 149\u201357.", "journal-title": "Invasion Metastasis"}, {"key": "BF02171709_CR42", "first-page": "113", "volume": "2", "author": "JP Nelles", "year": "1982", "unstructured": "Nelles JP, Schnebli HP. Are proteinase inhibitors potentially useful in tumor therapy? Invasion Metastasis 1982; 2: 113\u201324.", "journal-title": "Invasion Metastasis"}, {"key": "BF02171709_CR43", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1016/0092-8674(83)90093-4", "volume": "35", "author": "L Ossowski", "year": "1983", "unstructured": "Ossowski L, Reich E. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 1983; 35: 611\u20139.", "journal-title": "Cell"}, {"key": "BF02171709_CR44", "first-page": "1270", "volume": "48", "author": "VJ Hearing", "year": "1988", "unstructured": "Hearing VJ, Law L, Corti A, Appella E, Blasi F. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res 1988; 48: 1270\u20138.", "journal-title": "Cancer Res"}, {"key": "BF02171709_CR45", "doi-asserted-by": "crossref", "first-page": "282", "DOI": "10.1002/ijc.2910460224", "volume": "46", "author": "M Hoyhtya", "year": "1990", "unstructured": "Hoyhtya M, Hujanen E, Turpeenniemi-Hajenen T. Modulation of type IV collagenase activity and invasive behaviour of metastatic melanoma (A205B) cellsin vitro by monoclonal antibodies to type IV collagenase. Int J Cancer 1990; 46: 282\u20136.", "journal-title": "Int J Cancer"}, {"key": "BF02171709_CR46", "first-page": "4676", "volume": "50", "author": "MS Baker", "year": "1990", "unstructured": "Baker MS, Bleakley P, Woodrow GC, Doe WF. Inhibition of cancer cell urokinase by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation. Cancer Res 1990; 50: 4676\u201384.", "journal-title": "Cancer Res"}, {"key": "BF02171709_CR47", "first-page": "5539", "volume": "48", "author": "RM Schultz", "year": "1988", "unstructured": "Schultz RM, Silberman S, Persky B et al. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 1988; 48: 5539\u201345.", "journal-title": "Cancer Res"}, {"key": "BF02171709_CR48", "doi-asserted-by": "crossref", "first-page": "589", "DOI": "10.1093/jnci/82.7.589", "volume": "82", "author": "OA Alvarez", "year": "1990", "unstructured": "Alvarez OA, Carmichael DF, DeClerck YA. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 1990; 82: 589\u201395.", "journal-title": "J Natl Cancer Inst"}, {"key": "BF02171709_CR49", "first-page": "4485", "volume": "50", "author": "KM Yamada", "year": "1990", "unstructured": "Yamada KM, Kennedy DW, Yamada SS et al. Monoclonal antibodies and synthetic peptide inhibitors of human tumor cell migration. Cancer Res 1990; 50: 4485\u201396.", "journal-title": "Cancer Res"}, {"key": "BF02171709_CR50", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.1016/S0140-6736(89)90462-5", "volume": "2", "author": "B Allolio", "year": "1989", "unstructured": "Allolio B, Reincke M, Arlt W et al. Suramin for treatment of adrenocortical carcinoma. Lancet 1989; 2: 277.", "journal-title": "Lancet"}, {"key": "BF02171709_CR51", "doi-asserted-by": "crossref", "first-page": "422", "DOI": "10.1016/0277-5379(90)90008-H", "volume": "26", "author": "AT Oosterom Van", "year": "1990", "unstructured": "Van Oosterom AT, DeSmedt EA, Denis LJ et al. Suramin for prostatic cancer: a phase 1/11 study in advanced extensively pretreated disease. Eur J Cancer 1990; 26: 422.", "journal-title": "Eur J Cancer"}, {"key": "BF02171709_CR52", "first-page": "5937", "volume": "50", "author": "VS Zabrenetzky", "year": "1990", "unstructured": "Zabrenetzky VS, Kohn EC, Roberts DD et al. Suramin inhibits laminin and thrombospondin-mediated melanoma cell adhesion and migration and binding of these adhesive proteins to sulfatide. Cancer Res 1990; 50: 5937\u201342.", "journal-title": "Cancer Res"}, {"key": "BF02171709_CR53", "doi-asserted-by": "crossref", "first-page": "417", "DOI": "10.1016/0277-5379(90)90005-E", "volume": "26", "author": "JP Armand", "year": "1990", "unstructured": "Armand JP, Critkovic E. Suramin: a new therapeutic concept. Eur J Cancer 1990; 26: 417\u20139.", "journal-title": "Eur J Cancer"}], "container-title": ["Biotherapy"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF02171709.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF02171709/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF02171709", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 14]], "date-time": "2019-05-14T16:37:53Z", "timestamp": 1557851873000}, "score": 17.955767, "issued": {"date-parts": [[1992, 1]]}, "references-count": 53, "journal-issue": {"published-print": {"date-parts": [[1992, 1]]}, "issue": "1"}, "alternative-id": ["BF02171709"], "URL": "http://dx.doi.org/10.1007/bf02171709", "relation": {"cites": []}, "ISSN": ["0921-299X", "1573-8280"], "issn-type": [{"value": "0921-299X", "type": "print"}, {"value": "1573-8280", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T03:35:30Z", "timestamp": 1574739330251}, "reference-count": 62, "publisher": "Science Alert", "issue": "1", "content-domain": {"domain": ["scialert.net"], "crossmark-restriction": false}, "short-container-title": ["Asian J. of Dermatology"], "published-print": {"date-parts": [[2015, 1, 1]]}, "DOI": "10.3923/ajd.2015.1.12", "type": "journal-article", "created": {"date-parts": [[2015, 10, 28]], "date-time": "2015-10-28T07:57:38Z", "timestamp": 1446019058000}, "page": "1-12", "update-policy": "http://dx.doi.org/10.3923/crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Properties and Therapeutic Potential of Human Amniotic Membrane"], "prefix": "10.3923", "volume": "7", "author": [{"given": "Md.", "family": "Shaifur Ra", "sequence": "first", "affiliation": []}, {"given": "Rashedul", "family": "Islam", "sequence": "additional", "affiliation": []}, {"given": "S.M.", "family": "Asaduzzama", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Shahedur R", "sequence": "additional", "affiliation": []}], "member": "2297", "container-title": ["Asian Journal of Dermatology"], "link": [{"URL": "http://scialert.net/fulltext/?doi=ajd.2015.1.12&org=12", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 10, 29]], "date-time": "2016-10-29T06:23:41Z", "timestamp": 1477722221000}, "score": 17.916748, "issued": {"date-parts": [[2015, 1, 1]]}, "references-count": 62, "journal-issue": {"published-print": {"date-parts": [[2015, 1, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.3923/ajd.2015.1.12", "ISSN": ["1996-3424"], "issn-type": [{"value": "1996-3424", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T06:19:06Z", "timestamp": 1575267546701}, "reference-count": 67, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 3, 21]], "date-time": "2018-03-21T00:00:00Z", "timestamp": 1521590400000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/501100001602", "name": "Science Foundation Ireland", "doi-asserted-by": "publisher", "award": ["Strategic Research Cluster Award (08/SRC/B1410) to Molecular Therapeutics for Cancer Ireland"]}, {"DOI": "10.13039/501100001593", "name": "Irish Cancer Society", "doi-asserted-by": "publisher", "award": ["Collaborative Cancer Research Centre BREAST-PREDICT programme (CCRC13GAL)"]}, {"DOI": "10.13039/100010414", "name": "Health Research Board", "doi-asserted-by": "publisher", "award": ["Clinician Scientist Award (CSA/2007/11)"]}, {"name": "Cancer Clinical Research Trust", "award": []}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2018, 7]]}, "DOI": "10.1007/s10549-018-4753-7", "type": "journal-article", "created": {"date-parts": [[2018, 3, 21]], "date-time": "2018-03-21T14:14:56Z", "timestamp": 1521641696000}, "page": "213-219", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Mutant p53 in breast cancer: potential as a therapeutic target and biomarker"], "prefix": "10.1007", "volume": "170", "author": [{"given": "Michael J.", "family": "Duffy", "sequence": "first", "affiliation": []}, {"given": "Naoise C.", "family": "Synnott", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Crown", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 3, 21]]}, "reference": [{"key": "4753_CR1", "doi-asserted-by": "publisher", "first-page": "495", "DOI": "10.1038/nature12912", "volume": "505", "author": "MS Lawrence", "year": "2014", "unstructured": "Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, Meyerson M, Gabriel SB, Lander ES, Getz G (2014) Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505:495\u2013501", "journal-title": "Nature"}, {"key": "4753_CR2", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1038/nature12634", "volume": "502", "author": "C Kandoth", "year": "2013", "unstructured": "Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, Leiserson MD, Miller CA, Welch JS, Walter MJ, Wendl MC, Ley TJ, Wilson RK, Raphael BJ, Ding L (2013) Mutational landscape and significance across 12 major cancer types. Nature 502:333\u2013339", "journal-title": "Nature"}, {"key": "4753_CR3", "doi-asserted-by": "publisher", "first-page": "929", "DOI": "10.1016/j.cell.2014.06.049", "volume": "158", "author": "KA Hoadley", "year": "2014", "unstructured": "Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, Leiserson MD, Niu B, McLellan MD, Uzunangelov V, Zhang J, Kandoth C, Akbani R, Shen H, Omberg L, Chu A, Margolin AA, Van\u2019t Veer LJ, Lopez-Bigas N, Laird PW, Raphael BJ, Ding L, Robertson AG, Byers LA, Mills GB, Weinstein JN, Van Waes C, Chen Z, Collisson EA, Cancer Genome Atlas Research Network, Benz CC, Perou CM, Stuart JM (2014) Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158:929\u2013944", "journal-title": "Cell"}, {"key": "4753_CR4", "doi-asserted-by": "publisher", "first-page": "125", "DOI": "10.1016/j.ccell.2017.12.004", "volume": "33", "author": "R Yaeger", "year": "2018", "unstructured": "Yaeger R, Chatila WK, Lipsyc MD, Hechtman JF, Cercek A, Sanchez-Vega F, Jayakumaran G, Middha S, Zehir A, Donoghue MTA, You D, Viale A, Kemeny N, Segal NH, Stadler ZK, Varghese AM, Kundra R, Gao J, Syed A, Hyman DM, Vakiani E, Rosen N, Taylor BS, Ladanyi M, Berger MF, Solit DB, Shia J, Saltz L, Schultz N (2018) Clinical sequencing defines the genomic landscape of metastatic colorectal cancer. Cancer Cell 33:125\u2013136", "journal-title": "Cancer Cell"}, {"key": "4753_CR5", "doi-asserted-by": "publisher", "first-page": "61", "DOI": "10.1038/nature11412", "volume": "490", "author": "Cancer Genome Atlas Network", "year": "2012", "unstructured": "Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature 490:61\u201370", "journal-title": "Nature"}, {"key": "4753_CR6", "doi-asserted-by": "publisher", "first-page": "395", "DOI": "10.1038/nature10933", "volume": "486", "author": "SP Shah", "year": "2012", "unstructured": "Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, Bashashati A, Prentice LM, Khattra J, Burleigh A, Yap D, Bernard V, McPherson A, Shumansky K, Crisan A, Giuliany R, Heravi-Moussavi A, Rosner J, Lai D, Birol I, Varhol R, Tam A, Dhalla N, Zeng T, Ma K, Chan SK, Griffith M, Moradian A, Cheng SW, Morin GB, Watson P, Gelmon K, Chia S, Chin SF, Curtis C, Rueda OM, Pharoah PD, Damaraju S, Mackey J, Hoon K, Harkins T, Tadigotla V, Sigaroudinia M, Gascard P, Tlsty T, Costello JF, Meyer IM, Eaves CJ, Wasserman WW, Jones S, Huntsman D, Hirst M, Caldas C, Marra MA, Aparicio S (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486:395\u2013399", "journal-title": "Nature"}, {"key": "4753_CR7", "doi-asserted-by": "publisher", "first-page": "3569", "DOI": "10.1158/1078-0432.CCR-13-2943", "volume": "20", "author": "L Silwal-Pandit", "year": "2014", "unstructured": "Silwal-Pandit L, Vollan HK, Chin SF, Rueda OM, McKinney S, Osako T, Quigley DA, Kristensen VN, Aparicio S, B\u00f8rresen-Dale AL, Caldas C, Langer\u00f8d A (2014) TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance. Clin Cancer Res 20:3569\u20133580", "journal-title": "Clin Cancer Res"}, {"key": "4753_CR8", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1038/nature17676", "volume": "534", "author": "S Nik-Zainal", "year": "2016", "unstructured": "Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, Aure MR, Lingj\u00e6rde OC, Langer\u00f8d A, Ringn\u00e9r M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GK, Jang SJ, Jones DR, Kim HY, King TA, Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, O\u2019Meara S, Pauport\u00e9 I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodr\u00edguez-Gonz\u00e1lez FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA, Teague J, Tommasi S, Treilleux I, Van den Eynden GG, Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, Veer LV, Tutt A, Knappskog S, Tan BK, Jonkers J, Borg \u00c5, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JW, B\u00f8rresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR (2016) Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534:47\u201354", "journal-title": "Nature"}, {"key": "4753_CR9", "doi-asserted-by": "publisher", "first-page": "9952", "DOI": "10.18632/oncotarget.2481", "volume": "5", "author": "M Kriegsmann", "year": "2014", "unstructured": "Kriegsmann M, Endris V, Wolf T, Pfarr N, Stenzinger A, Loibl S, Denkert C, Schneeweiss A, Budczies J, Sinn P, Weichert W (2014) Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3\u00a0K pathway alterations and clinically relevant entity subgroup specific differences. Oncotarget 5:9952\u20139965", "journal-title": "Oncotarget"}, {"key": "4753_CR10", "doi-asserted-by": "publisher", "first-page": "1062", "DOI": "10.1016/j.cell.2017.08.028", "volume": "170", "author": "ER Kastenhuber", "year": "2017", "unstructured": "Kastenhuber ER, Lowe SW (2017) Putting p53 in context. Cell 170:1062\u20131078", "journal-title": "Cell"}, {"key": "4753_CR11", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1038/nrc3711", "volume": "14", "author": "KT Bieging", "year": "2014", "unstructured": "Bieging KT, Mello SS, Attardi LD (2014) Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 14:359\u2013370", "journal-title": "Nat Rev Cancer"}, {"key": "4753_CR12", "doi-asserted-by": "publisher", "first-page": "393", "DOI": "10.1038/nrm4007", "volume": "16", "author": "F Kruiswijk", "year": "2015", "unstructured": "Kruiswijk F, Labuschagne CF, Vousden KH (2015) P53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol 16:393\u2013405", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "4753_CR13", "doi-asserted-by": "publisher", "first-page": "654", "DOI": "10.1186/1471-2407-10-654", "volume": "10", "author": "H Holstege", "year": "2010", "unstructured": "Holstege H, Horlings HM, Velds A, Langer\u00f8d A, B\u00f8rresen-Dale AL, van de Vijver MJ, Nederlof PM, Jonkers J (2010) BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations. BMC Cancer 10:654", "journal-title": "BMC Cancer"}, {"key": "4753_CR14", "doi-asserted-by": "publisher", "first-page": "283ra54", "DOI": "10.1126/scitranslmed.aaa1408", "volume": "7", "author": "N McGranahan", "year": "2015", "unstructured": "McGranahan N, Favero F, de Bruin EC, Birkbak NJ, Szallasi Z, Swanton C (2015) Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci Transl Med 7:283ra54", "journal-title": "Sci Transl Med"}, {"key": "4753_CR15", "doi-asserted-by": "publisher", "first-page": "751", "DOI": "10.1038/nm.3886", "volume": "21", "author": "LR Yates", "year": "2015", "unstructured": "Yates LR, Gerstung M, Knappskog S, Desmedt C, Gundem G, Van Loo P, Aas T, Alexandrov LB, Larsimont D, Davies H, Li Y, Ju YS, Ramakrishna M, Haugland HK, Lilleng PK, Nik-Zainal S, McLaren S, Butler A, Martin S, Glodzik D, Menzies A, Raine K, Hinton J, Jones D, Mudie LJ, Jiang B, Vincent D, Greene-Colozzi A, Adnet PY, Fatima A, Maetens M, Ignatiadis M, Stratton MR, Sotiriou C, Richardson AL, L\u00f8nning PE, Wedge DC, Campbell PJ (2015) Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat Med 21:751\u2013759", "journal-title": "Nat Med"}, {"key": "4753_CR16", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1016/j.cell.2017.12.007", "volume": "172", "author": "AK Casasent", "year": "2018", "unstructured": "Casasent AK, Schalck A, Gao R, Sei E, Long A, Pangburn W, Casasent T, Meric-Bernstam F, Edgerton ME, Navin NE (2018) Multiclonal invasion in breast tumors identified by topographic single cell sequencing. Cell 172:205\u2013217", "journal-title": "Cell"}, {"key": "4753_CR17", "doi-asserted-by": "publisher", "first-page": "700", "DOI": "10.1093/jnci/93.9.700", "volume": "93", "author": "SJ Done", "year": "2001", "unstructured": "Done SJ, Eskandarian S, Bull S, Redston M, Andrulis IL (2001) p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast. J Natl Cancer Inst 93:700\u2013704", "journal-title": "J Natl Cancer Inst"}, {"key": "4753_CR18", "doi-asserted-by": "publisher", "first-page": "214", "DOI": "10.1016/j.molonc.2009.03.001", "volume": "3", "author": "W Ful Zhou", "year": "2009", "unstructured": "Ful Zhou W, Muggerud AA, Vu P, Due EU, S\u00f8rlie T, B\u00f8rresen-Dale AL, W\u00e4rnberg F, Langer\u00f8d A (2009) Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution. Mol Oncol 3:214\u2013219", "journal-title": "Mol Oncol"}, {"issue": "111\u20138", "key": "4753_CR19", "first-page": "53", "volume": "65", "author": "SJ Done", "year": "2001", "unstructured": "Done SJ, Arneson CR, Oz\u00e7elik H, Redston M, Andrulis IL (2001) P53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast. Breast Cancer Res Treat 65(111\u20138):53", "journal-title": "Breast Cancer Res Treat"}, {"key": "4753_CR20", "first-page": "785", "volume": "58", "author": "SJ Done", "year": "1998", "unstructured": "Done SJ, Arneson NC, Oz\u00e7elik H, Redston M, Andrulis IL (1998) p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias. Cancer Res 58:785\u2013789", "journal-title": "Cancer Res"}, {"key": "4753_CR21", "doi-asserted-by": "publisher", "first-page": "160007", "DOI": "10.1038/npjbcancer.2016.7", "volume": "2", "author": "MA Troester", "year": "2016", "unstructured": "Troester MA, Hoadley KA, D\u2019Arcy M et al (2016) DNA defects, epigenetics and gene expression in cancer-adjacent breast: a study from the Cancer Genome Atlas. NPJ Breast Cancer 2:160007. https://doi.org/10.1038/npjcancer.2016.7", "journal-title": "NPJ Breast Cancer"}, {"key": "4753_CR22", "doi-asserted-by": "publisher", "first-page": "2471", "DOI": "10.1002/ijc.27632", "volume": "131", "author": "MJ Duffy", "year": "2012", "unstructured": "Duffy MJ, McGowan PM, Crown J (2012) Targeted therapy for triple-negative breast cancer: where are we? Int J Cancer 131:2471\u20132477", "journal-title": "Int J Cancer"}, {"key": "4753_CR23", "doi-asserted-by": "publisher", "first-page": "397", "DOI": "10.1038/bjc.2011.464", "volume": "106", "author": "C Lo Nigro", "year": "2012", "unstructured": "Lo Nigro C, Vivenza D, Monteverde M, Lattanzio L, Gojis O, Garrone O, Comino A, Merlano M, Quinlan PR, Syed N, Purdie CA, Thompson A, Palmieri C, Crook T (2012) High frequency of complex TP53 mutations in CNS metastases from breast cancer. Br J Cancer 106:397\u2013404", "journal-title": "Br J Cancer"}, {"key": "4753_CR24", "doi-asserted-by": "publisher", "first-page": "2622", "DOI": "10.1016/j.febslet.2014.04.017", "volume": "588", "author": "VJ Bykov", "year": "2014", "unstructured": "Bykov VJ, Wiman KG (2014) Mutant p53 reactivation by small molecules makes its way to the clinic. FEBS Lett 588:2622\u20132627", "journal-title": "FEBS Lett"}, {"key": "4753_CR25", "doi-asserted-by": "publisher", "first-page": "4171", "DOI": "10.1007/s00018-017-2575-0", "volume": "74", "author": "D Zhao", "year": "2017", "unstructured": "Zhao D, Tahaney WM, Mazumdar A, Savage MI, Brown PH (2017) Molecularly targeted therapies for p53-mutant cancers. Cell Mol Life Sci 74:4171\u20134187", "journal-title": "Cell Mol Life Sci"}, {"key": "4753_CR26", "doi-asserted-by": "publisher", "first-page": "258", "DOI": "10.1016/j.ejca.2017.06.023", "volume": "83", "author": "MJ Duffy", "year": "2017", "unstructured": "Duffy MJ, Synnott NC, Crown J (2017) Mutant p53 as a target for cancer treatment. Eur J Cancer 83:258\u2013265", "journal-title": "Eur J Cancer"}, {"key": "4753_CR27", "doi-asserted-by": "publisher", "first-page": "282", "DOI": "10.1038/nm0302-282", "volume": "8", "author": "VJ Bykov", "year": "2002", "unstructured": "Bykov VJ, Issaeva N, Shilov A, Hultcrantz M, Pugacheva E, Chumakov P, Bergman J, Wiman KG, Selivanova G (2002) Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. Nat Med 8:282\u2013288", "journal-title": "Nat Med"}, {"key": "4753_CR28", "doi-asserted-by": "publisher", "first-page": "3484", "DOI": "10.1038/sj.onc.1208419", "volume": "24", "author": "VJ Bykov", "year": "2005", "unstructured": "Bykov VJ, Zache N, Stridh H, Westman J, Bergman J, Selivanova G, Wiman KG (2005) PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis. Oncogene 24:3484\u20133491", "journal-title": "Oncogene"}, {"key": "4753_CR29", "first-page": "777", "volume": "31", "author": "Y Liang", "year": "2007", "unstructured": "Liang Y, Besch-Williford C, Benakanakere I, Hyder SM (2007) Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells. Int J Oncol 31:777\u2013784", "journal-title": "Int J Oncol"}, {"key": "4753_CR30", "first-page": "1015", "volume": "35", "author": "Y Liang", "year": "2009", "unstructured": "Liang Y, Besch-Williford C, Hyder SM (2009) PRIMA-1 inhibits growth of breast cancer cells by re-activating mutant p53 protein. Int J Oncol 35:1015\u20131023", "journal-title": "Int J Oncol"}, {"key": "4753_CR31", "doi-asserted-by": "publisher", "first-page": "407", "DOI": "10.1007/s10549-010-0851-x", "volume": "125", "author": "Y Liang", "year": "2011", "unstructured": "Liang Y, Besch-Williford C, Benakanakere I, Thorpe PE, Hyder SM (2011) Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors. Breast Cancer Res Treat 125:407\u2013420", "journal-title": "Breast Cancer Res Treat"}, {"key": "4753_CR32", "doi-asserted-by": "publisher", "first-page": "234", "DOI": "10.1002/ijc.30425", "volume": "140", "author": "NC Synnott", "year": "2017", "unstructured": "Synnott NC, Murray A, McGowan PM, Kiely M, Kiely PA, O\u2019Donovan N, O\u2019Connor DP, Gallagher WM, Crown J, Duffy MJ (2017) Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer? Int J Cancer 140:234\u2013246", "journal-title": "Int J Cancer"}, {"key": "4753_CR33", "doi-asserted-by": "publisher", "first-page": "e14098", "DOI": "10.1200/JCO.2017.35.15_suppl.e14098", "volume": "35", "author": "NC Synnott", "year": "2017", "unstructured": "Synnott NC, Murray AM, O\u2019Donovan N, Duffy MJ, Crown J (2017) Combined treatment using the anti-p53 drug, APR-246 and eribulin: synergistic growth inhibition in p53-mutated breast cancer cells. J Clin Oncol 35:e14098", "journal-title": "J Clin Oncol"}, {"key": "4753_CR34", "doi-asserted-by": "publisher", "first-page": "2331", "DOI": "10.1158/1535-7163.MCT-12-1166", "volume": "12", "author": "MN Saha", "year": "2013", "unstructured": "Saha MN, Jiang H, Yang Y, Reece D, Chang H (2013) PRIMA-1Met/APR-246 displays high antitumor activity in multiple myeloma by induction of p73 and Noxa. Mol Cancer Ther 12:2331\u20132341", "journal-title": "Mol Cancer Ther"}, {"key": "4753_CR35", "doi-asserted-by": "publisher", "first-page": "799", "DOI": "10.1080/15384047.2015.1026482", "volume": "16", "author": "M Sobhani", "year": "2015", "unstructured": "Sobhani M, Abdi J, Chen C, Chang H (2015) PRIMA-1Met induces apoptosis in Waldenstr\u00f6m\u2019s Macroglobulinemia cells independent of p53. Cancer Biol Ther 16:799\u2013806", "journal-title": "Cancer Biol Ther"}, {"key": "4753_CR36", "doi-asserted-by": "publisher", "first-page": "6442", "DOI": "10.1038/onc.2010.382", "volume": "29", "author": "N R\u00f6kaeus", "year": "2010", "unstructured": "R\u00f6kaeus N, Shen J, Eckhardt I, Bykov VJ, Wiman KG, Wilhelm MT (2010) PRIMA-1(MET)/APR-246 targets mutant forms of p53 family members p63 and p73. Oncogene 29:6442\u20136451", "journal-title": "Oncogene"}, {"key": "4753_CR37", "doi-asserted-by": "publisher", "first-page": "931", "DOI": "10.1038/nrd4002", "volume": "12", "author": "C Gorrini", "year": "2013", "unstructured": "Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12:931\u2013947", "journal-title": "Nat Rev Drug Discov"}, {"key": "4753_CR38", "doi-asserted-by": "publisher", "first-page": "e881", "DOI": "10.1038/cddis.2013.417", "volume": "4", "author": "X Peng", "year": "2013", "unstructured": "Peng X, Zhang MQ, Conserva F, Hosny G, Selivanova G, Bykov VJ, Arn\u00e9r ES, Wiman KG (2013) APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase. Cell Death Dis 4:e881", "journal-title": "Cell Death Dis"}, {"key": "4753_CR39", "doi-asserted-by": "publisher", "first-page": "14844", "DOI": "10.1038/ncomms14844", "volume": "8", "author": "DS Liu", "year": "2017", "unstructured": "Liu DS, Duong CP, Haupt S, Montgomery KG, House CM, Azar WJ, Pearson HB, Fisher OM, Read M, Guerra GR, Haupt Y, Cullinane C, Wiman KG, Abrahmsen L, Phillips WA, Clemons NJ (2017) Inhibiting the system xC-/glutathione axis selectively targets cancers with mutant-p53 accumulation. Nat Commun 8:14844", "journal-title": "Nat Commun"}, {"key": "4753_CR40", "doi-asserted-by": "publisher", "first-page": "3633", "DOI": "10.1200/JCO.2011.40.7783", "volume": "30", "author": "S Lehmann", "year": "2012", "unstructured": "Lehmann S, Bykov VJ, Ali D, Andr\u00e9n O, Cherif H, Tidefelt U, Uggla B, Yachnin J, Juliusson G, Moshfegh A, Paul C, Wiman KG, Andersson PO (2012) Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer. J Clin Oncol 30:3633\u20133639", "journal-title": "J Clin Oncol"}, {"key": "4753_CR41", "unstructured": "Gourley C, Green J, Gabra H, Vergote I, Basu B, Brenton JD, Bj\u00f6rklund U, Smith A, Von Euler M (2016) PISARRO: a EUTROC phase Ib study of APR-246 in combination with carboplatin (C) and pegylated liposomal doxorubicin (PLD) in platinum sensitive relapsed high grade serous ovarian cancer (HGSOC). J Clin Oncol 34 (suppl; abstr 5571)", "DOI": "10.1200/JCO.2016.34.15_suppl.5571", "doi-asserted-by": "crossref"}, {"key": "4753_CR42", "unstructured": "Gourley C, Gabra H, Vergote I, Basu B, Brenton J, Von Euler M, Bj\u00f6rklund U, Smith AM, Green J (2015) EUTROC PiSARRO: a phase Ib study combining APR-246 with standard chemotherapy in platinum sensitive relapsed high grade serous ovarian carcinoma (HGSOC). J Clin Oncol 33 (suppl; abstr TPS5605)", "DOI": "10.1200/jco.2015.33.15_suppl.tps5605", "doi-asserted-by": "crossref"}, {"key": "4753_CR43", "doi-asserted-by": "publisher", "first-page": "E5271", "DOI": "10.1073/pnas.1610421113", "volume": "113", "author": "MR Bauer", "year": "2016", "unstructured": "Bauer MR, Joerger AC, Fersht AR (2016) 2-Sulfonylpyrimidines: mild alkylating agents with anticancer activity toward p53-compromised cells. Proc Natl Acad Sci U S A 113:E5271\u2013E5280", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "4753_CR44", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1016/j.canlet.2017.09.053", "volume": "414", "author": "NC Synnott", "year": "2018", "unstructured": "Synnott NC, Bauer MR, Madden S, Murray A, Klinger R, O\u2019Donovan N, O\u2019Connor D, Gallagher WM, Crown J, Fersht AR, Duffy MJ (2018) Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigation with the anti-p53 drug, PK11007. Cancer Lett 414:99\u2013106", "journal-title": "Cancer Lett"}, {"key": "4753_CR45", "unstructured": "Synnott NC, Bauer MR, Madden SF, Murray AM, Klinger R, O\u2019Donovan N, O\u2019Connor D, Gallagher WM, Crown J, Fersht AR, Duffy MJ (2017) Targeting mutant p53 with PK11007: a new approach for the treatment of patients with triple-negative breast cancer? J Clin Oncol 35 (suppl; abstr e14099)", "DOI": "10.1200/JCO.2017.35.15_suppl.e14099", "doi-asserted-by": "crossref"}, {"key": "4753_CR46", "doi-asserted-by": "publisher", "first-page": "41363", "DOI": "10.18632/oncotarget.9133", "volume": "7", "author": "KY Salim", "year": "2016", "unstructured": "Salim KY, Maleki Vareki S, Danter WR, Koropatnick J (2016) COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo. Oncotarget 7:41363\u201341379", "journal-title": "Oncotarget"}, {"key": "4753_CR47", "unstructured": "http://www.pharmaceutical-technology.com/news/newscritical-outcome-seeks-fda-orphan-drug-status-for-ovarian-cancer-drug-coti-2-4210077/ . Accessed 6 Apr 2014"}, {"key": "4753_CR48", "doi-asserted-by": "publisher", "first-page": "845", "DOI": "10.1093/jnci/84.11.845", "volume": "84", "author": "AD Thor", "year": "1992", "unstructured": "Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH et al (1992) Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84:845\u2013855", "journal-title": "J Natl Cancer Inst"}, {"key": "4753_CR49", "doi-asserted-by": "publisher", "first-page": "1109", "DOI": "10.1093/jnci/84.14.1109", "volume": "84", "author": "J Isola", "year": "1992", "unstructured": "Isola J, Visakorpi T, Holli K, Kallioniemi OP (1992) Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84:1109\u20131114", "journal-title": "J Natl Cancer Inst"}, {"key": "4753_CR50", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.1002/ijc.2910550110", "volume": "55", "author": "P Lipponen", "year": "1993", "unstructured": "Lipponen P, Ji H, Aaltomaa S, Syrj\u00e4nen S, Syrj\u00e4nen K (1993) p53 protein expression in breast cancer as related to histopathological characteristics and prognosis. Int J Cancer 55:51\u201356", "journal-title": "Int J Cancer"}, {"key": "4753_CR51", "doi-asserted-by": "publisher", "first-page": "1968", "DOI": "10.1038/sj.bjc.6690628", "volume": "80", "author": "PD Pharoah", "year": "1999", "unstructured": "Pharoah PD, Day NE, Caldas C (1999) Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer 80:1968\u20131973", "journal-title": "Br J Cancer"}, {"key": "4753_CR52", "doi-asserted-by": "publisher", "first-page": "1157", "DOI": "10.1158/1078-0432.CCR-05-1029", "volume": "12", "author": "M Olivier", "year": "2006", "unstructured": "Olivier M, Langer\u00f8d A, Carrieri P, Bergh J, Klaar S, Eyfjord J, Theillet C, Rodriguez C, Lidereau R, Bi\u00e8che I, Varley J, Bignon Y, Uhrhammer N, Winqvist R, Jukkola-Vuorinen A, Niederacher D, Kato S, Ishioka C, Hainaut P, B\u00f8rresen-Dale AL (2006) The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin Cancer Res 12:1157\u20131167", "journal-title": "Clin Cancer Res"}, {"key": "4753_CR53", "doi-asserted-by": "publisher", "first-page": "2157", "DOI": "10.1038/sj.onc.1210302", "volume": "26", "author": "A Petitjean", "year": "2007", "unstructured": "Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M (2007) TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 26:2157\u20132165", "journal-title": "Oncogene"}, {"key": "4753_CR54", "doi-asserted-by": "publisher", "first-page": "R30", "DOI": "10.1186/bcr1675", "volume": "9", "author": "A Langer\u00f8d", "year": "2007", "unstructured": "Langer\u00f8d A, Zhao H, Borgan \u00d8, Nesland JM, Bukholm IR, Ikdahl T, K\u00e5resen R, B\u00f8rresen-Dale AL, Jeffrey SS (2007) TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer. Breast Cancer Res 9:R30", "journal-title": "Breast Cancer Res"}, {"key": "4753_CR55", "doi-asserted-by": "publisher", "first-page": "284", "DOI": "10.3389/fonc.2015.00284", "volume": "5", "author": "R Vijayakumaran", "year": "2015", "unstructured": "Vijayakumaran R, Tan KH, Miranda PJ, Haupt S, Haupt Y (2015) Regulation of mutant p53 protein expression. Front Oncol 5:284. https://doi.org/10.3389/fonc.2015.00284", "journal-title": "Front Oncol"}, {"key": "4753_CR56", "doi-asserted-by": "publisher", "first-page": "329", "DOI": "10.1002/path.1711660402", "volume": "166", "author": "D Wynford-Thomas", "year": "1992", "unstructured": "Wynford-Thomas D (1992) P53 in tumour pathology: can we trust immunocytochemistry? J Pathol 166:329\u2013330", "journal-title": "J Pathol"}, {"key": "4753_CR57", "doi-asserted-by": "publisher", "first-page": "238", "DOI": "10.1002/path.4356", "volume": "233", "author": "P Bouchalova", "year": "2014", "unstructured": "Bouchalova P, Nenutil R, Muller P, Hrstka R, Appleyard MV, Murray K, Jordan LB, Purdie CA, Quinlan P, Thompson AM, Vojtesek B, Coates PJ (2014) Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status. J Pathol 233:238\u2013246", "journal-title": "J Pathol"}, {"key": "4753_CR58", "doi-asserted-by": "publisher", "first-page": "348", "DOI": "10.1002/(SICI)1096-9896(199804)184:4<348::AID-PATH1227>3.0.CO;2-O", "volume": "184", "author": "V Save", "year": "1998", "unstructured": "Save V, Nylander K, Hall PA (1998) Why is p53 protein stabilized in neoplasia? some answers but many more questions? J Pathol 184:348\u2013350", "journal-title": "J Pathol"}, {"key": "4753_CR59", "doi-asserted-by": "publisher", "first-page": "R143", "DOI": "10.1186/bcr3348", "volume": "14", "author": "AS Coates", "year": "2012", "unstructured": "Coates AS, Millar EK, O\u2019Toole SA, Molloy TJ, Viale G, Goldhirsch A, Regan MM, Gelber RD, Sun Z, Castiglione-Gertsch M, Gusterson B, Musgrove EA, Sutherland RL (2012) Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX. Breast Cancer Res 14:R143", "journal-title": "Breast Cancer Res"}, {"key": "4753_CR60", "doi-asserted-by": "publisher", "first-page": "5170", "DOI": "10.1158/1078-0432.CCR-11-0484", "volume": "17", "author": "JF Lara", "year": "2011", "unstructured": "Lara JF, Thor AD, Dressler LG, Broadwater G, Bleiweiss IJ, Edgerton S, Cowan D, Goldstein LJ, Martino S, Ingle JN, Henderson IC, Norton L, Winer EP, Hudis CA, Ellis MJ, Berry DA, Hayes DF (2011) p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905). Clin Cancer Res 17:5170\u20135178", "journal-title": "Clin Cancer Res"}, {"key": "4753_CR61", "doi-asserted-by": "publisher", "first-page": "527", "DOI": "10.1016/S1470-2045(11)70094-8", "volume": "12", "author": "H Bonnefoi", "year": "2011", "unstructured": "Bonnefoi H, Piccart M, Bogaerts J, Mauriac L, Fumoleau P, Brain E, Petit T, Rouanet P, Jassem J, Blot E, Zaman K, Cufer T, Lortholary A, Lidbrink E, Andre S, Litiere S, Lago LD, Becette V, Cameron DA, Bergh J, Iggo R (2011) TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial. Lancet Oncol 12:527\u2013539", "journal-title": "Lancet Oncol"}, {"key": "4753_CR62", "doi-asserted-by": "publisher", "first-page": "R70", "DOI": "10.1186/bcr3179", "volume": "14", "author": "L Fernandez-Cuesta", "year": "2012", "unstructured": "Fernandez-Cuesta L, Oakman C, Falagan-Lotsch P, Smoth KS, Quinaux E, Buyse M, Dolci MS, De Azambuja E, Hainaut P, Dell\u2019orto P, Larsimont D, Francis PA, Crown J, Piccart-Gebhart M, Viale G, Di Leo A, Olivier M (2012) Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane based adjuvant therapy: results from the BIG 02-98 phase III trial. Breast Cancer Res 14:R70", "journal-title": "Breast Cancer Res"}, {"key": "4753_CR63", "doi-asserted-by": "publisher", "first-page": "32731", "DOI": "10.18632/oncotarget.9022", "volume": "7", "author": "G Fountzilas", "year": "2016", "unstructured": "Fountzilas G, Giannoulatou E, Alexopoulou Z, Zagouri F, Timotheadou E, Papadopoulou K, Lakis S, Bobos M, Poulios C, Sotiropoulou M, Lyberopoulou A, Gogas H, Pentheroudakis G, Pectasides D, Koutras A, Christodoulou C, Papandreou C, Samantas E, Papakostas P, Kosmidis P, Bafaloukos D, Karanikiotis C, Dimopoulos MA, Kotoula V (2016) TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting. Oncotarget 7:32731\u201332753", "journal-title": "Oncotarget"}, {"key": "4753_CR64", "doi-asserted-by": "publisher", "first-page": "1815", "DOI": "10.1038/cdd.2011.120", "volume": "18", "author": "V Marcel", "year": "2011", "unstructured": "Marcel V, Dichtel-Danjoy ML, Sagne C, Hafsi H, Ma D, Ortiz-Cuaran S, Olivier M, Hall J, Mollereau B, Hainaut P, Bourdon JC (2011) Biological functions of p53 isoforms through evolution: lessons from animal and cellular models. Cell Death Differ 18:1815\u20131824", "journal-title": "Cell Death Differ"}, {"key": "4753_CR65", "doi-asserted-by": "publisher", "first-page": "R7", "DOI": "10.1186/bcr2811", "volume": "13", "author": "JC Bourdon", "year": "2011", "unstructured": "Bourdon JC, Khoury MP, Diot A, Baker L, Fernandes K, Aoubala M, Quinlan P, Purdie CA, Jordan LB, Prats AC, Lane DP, Thompson AM (2011) p53 mutant breast cancer patients expressing p53\u03b3 have as good a prognosis as wild-type p53 breast cancer patients. Breast Cancer Res 13:R7", "journal-title": "Breast Cancer Res"}, {"key": "4753_CR66", "doi-asserted-by": "publisher", "first-page": "586", "DOI": "10.1093/carcin/bgt411", "volume": "35", "author": "KA Avery-Kiejda", "year": "2014", "unstructured": "Avery-Kiejda KA, Morten B, Wong-Brown MW, Mathe A, Scott RJ (2014) The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome. Carcinogenesis 35:586\u2013596", "journal-title": "Carcinogenesis"}, {"key": "4753_CR67", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1016/j.celrep.2017.11.112", "volume": "22", "author": "LA Hwang", "year": "2018", "unstructured": "Hwang LA, Phang BH, Liew OW, Iqbal J, Koh XH, Koh XY, Othman R, Xue Y, Richards AM, Lane DP, Sabapathy K (2018) Monoclonal antibodies against specific p53 hotspot mutants as potential tools for precision medicine. Cell Rep 22:299\u2013312", "journal-title": "Cell Rep"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s10549-018-4753-7/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10549-018-4753-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10549-018-4753-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 13]], "date-time": "2019-10-13T06:35:25Z", "timestamp": 1570948525000}, "score": 17.913435, "issued": {"date-parts": [[2018, 3, 21]]}, "references-count": 67, "journal-issue": {"published-print": {"date-parts": [[2018, 7]]}, "issue": "2"}, "alternative-id": ["4753"], "URL": "http://dx.doi.org/10.1007/s10549-018-4753-7", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"], "assertion": [{"value": "24 January 2018", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "13 March 2018", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "21 March 2018", "order": 3, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}